today at IDS 2021 Show Preview (International)
The show must go on—dental industry looks ahead confidently
/ “IDS will light the way for the whole dental industry” – An interview with Mark Stephen Pace
/ News
/ For patients looking for high-quality dentistry, IDS provides the answers
/ News
/ Top three trends influencing US dental bone grafting industry in 2021
/ The pandemic continues to bite: COVID-19 and the dental market
/ Products in focus
/ Practice & science
/ Travel tips, useful information & imprint
Array
(
[post_data] => WP_Post Object
(
[ID] => 83162
[post_author] => 0
[post_date] => 2021-09-10 10:11:07
[post_date_gmt] => 2021-09-10 10:11:07
[post_content] =>
[post_title] => today at IDS 2021 Show Preview (International)
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => today-at-ids-2021-show-preview-international
[to_ping] =>
[pinged] =>
[post_modified] => 2024-10-24 04:20:12
[post_modified_gmt] => 2024-10-24 04:20:12
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://e.dental-tribune.com/epaper/today-at-ids-2021-show-preview-english/
[menu_order] => 0
[post_type] => epaper
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[id] => 83162
[id_hash] => 4f049e3526aba372da864f05a36bdae6a5d3600208d1a3f8e015b775f163865a
[post_type] => epaper
[post_date] => 2021-09-10 10:11:07
[fields] => Array
(
[pdf] => Array
(
[ID] => 83163
[id] => 83163
[title] => today at IDS 2021 Show Preview (English).pdf
[filename] => today at IDS 2021 Show Preview (English).pdf
[filesize] => 0
[url] => https://e.dental-tribune.com/wp-content/uploads/today at IDS 2021 Show Preview (English).pdf
[link] => https://e.dental-tribune.com/epaper/today-at-ids-2021-show-preview-international/today-at-ids-2021-show-preview-english-pdf-2/
[alt] =>
[author] => 0
[description] =>
[caption] =>
[name] => today-at-ids-2021-show-preview-english-pdf-2
[status] => inherit
[uploaded_to] => 83162
[date] => 2024-10-24 04:20:06
[modified] => 2024-10-24 04:20:06
[menu_order] => 0
[mime_type] => application/pdf
[type] => application
[subtype] => pdf
[icon] => https://e.dental-tribune.com/wp-includes/images/media/document.png
)
[cf_issue_name] => today at IDS 2021 Show Preview (International)
[cf_edition_number] => 100921
[contents] => Array
(
[0] => Array
(
[from] => 1
[to] => 1
[title] => The show must go on—dental industry looks ahead confidently
[description] => The show must go on—dental industry looks ahead confidently
)
[1] => Array
(
[from] => 2
[to] => 2
[title] => “IDS will light the way for the whole dental industry” – An interview with Mark Stephen Pace
[description] => “IDS will light the way for the whole dental industry” – An interview with Mark Stephen Pace
)
[2] => Array
(
[from] => 4
[to] => 4
[title] => News
[description] => News
)
[3] => Array
(
[from] => 6
[to] => 6
[title] => For patients looking for high-quality dentistry, IDS provides the answers
[description] => For patients looking for high-quality dentistry, IDS provides the answers
)
[4] => Array
(
[from] => 7
[to] => 7
[title] => News
[description] => News
)
[5] => Array
(
[from] => 8
[to] => 8
[title] => Top three trends influencing US dental bone grafting industry in 2021
[description] => Top three trends influencing US dental bone grafting industry in 2021
)
[6] => Array
(
[from] => 9
[to] => 9
[title] => The pandemic continues to bite: COVID-19 and the dental market
[description] => The pandemic continues to bite: COVID-19 and the dental market
)
[7] => Array
(
[from] => 10
[to] => 11
[title] => Products in focus
[description] => Products in focus
)
[8] => Array
(
[from] => 12
[to] => 13
[title] => Practice & science
[description] => Practice & science
)
[9] => Array
(
[from] => 14
[to] => 15
[title] => Travel tips, useful information & imprint
[description] => Travel tips, useful information & imprint
)
)
)
[permalink] => https://e.dental-tribune.com/epaper/today-at-ids-2021-show-preview-international/
[post_title] => today at IDS 2021 Show Preview (International)
[client] =>
[client_slug] =>
[pages_generated] =>
[pages] => Array
(
[1] => Array
(
[image_url] => Array
(
[2000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/83162-8d448724/2000/page-0.jpg
[1000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/83162-8d448724/1000/page-0.jpg
[200] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/83162-8d448724/200/page-0.jpg
)
[key] => Array
(
[2000] => 83162-8d448724/2000/page-0.jpg
[1000] => 83162-8d448724/1000/page-0.jpg
[200] => 83162-8d448724/200/page-0.jpg
)
[ads] => Array
(
)
[html_content] =>
)
[2] => Array
(
[image_url] => Array
(
[2000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/83162-8d448724/2000/page-1.jpg
[1000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/83162-8d448724/1000/page-1.jpg
[200] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/83162-8d448724/200/page-1.jpg
)
[key] => Array
(
[2000] => 83162-8d448724/2000/page-1.jpg
[1000] => 83162-8d448724/1000/page-1.jpg
[200] => 83162-8d448724/200/page-1.jpg
)
[ads] => Array
(
)
[html_content] =>
)
[3] => Array
(
[image_url] => Array
(
[2000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/83162-8d448724/2000/page-2.jpg
[1000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/83162-8d448724/1000/page-2.jpg
[200] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/83162-8d448724/200/page-2.jpg
)
[key] => Array
(
[2000] => 83162-8d448724/2000/page-2.jpg
[1000] => 83162-8d448724/1000/page-2.jpg
[200] => 83162-8d448724/200/page-2.jpg
)
[ads] => Array
(
[0] => Array
(
[post_data] => WP_Post Object
(
[ID] => 83164
[post_author] => 0
[post_date] => 2024-10-24 04:20:06
[post_date_gmt] => 2024-10-24 04:20:06
[post_content] =>
[post_title] => epaper-83162-page-3-ad-83164
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => epaper-83162-page-3-ad-83164
[to_ping] =>
[pinged] =>
[post_modified] => 2024-10-24 04:20:06
[post_modified_gmt] => 2024-10-24 04:20:06
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://e.dental-tribune.com/ad/epaper-83162-page-3-ad/
[menu_order] => 0
[post_type] => ad
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[id] => 83164
[id_hash] => 328c9eb9f9cc506683367121c0279b87bc1e46ff8b16a4fe7229666a46950afd
[post_type] => ad
[post_date] => 2024-10-24 04:20:06
[fields] => Array
(
[url] => https://de.dental-tribune.com/c/exocad-2/
[link] => URL
)
[permalink] => https://e.dental-tribune.com/ad/epaper-83162-page-3-ad-83164/
[post_title] => epaper-83162-page-3-ad-83164
[post_status] => publish
[position] => 0.67114093959732,0.15649452269171,99.10514541387,99.687010954617
[belongs_to_epaper] => 83162
[page] => 3
[cached] => false
)
)
[html_content] =>
)
[4] => Array
(
[image_url] => Array
(
[2000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/83162-8d448724/2000/page-3.jpg
[1000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/83162-8d448724/1000/page-3.jpg
[200] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/83162-8d448724/200/page-3.jpg
)
[key] => Array
(
[2000] => 83162-8d448724/2000/page-3.jpg
[1000] => 83162-8d448724/1000/page-3.jpg
[200] => 83162-8d448724/200/page-3.jpg
)
[ads] => Array
(
)
[html_content] =>
)
[5] => Array
(
[image_url] => Array
(
[2000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/83162-8d448724/2000/page-4.jpg
[1000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/83162-8d448724/1000/page-4.jpg
[200] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/83162-8d448724/200/page-4.jpg
)
[key] => Array
(
[2000] => 83162-8d448724/2000/page-4.jpg
[1000] => 83162-8d448724/1000/page-4.jpg
[200] => 83162-8d448724/200/page-4.jpg
)
[ads] => Array
(
[0] => Array
(
[post_data] => WP_Post Object
(
[ID] => 83165
[post_author] => 0
[post_date] => 2024-10-24 04:20:06
[post_date_gmt] => 2024-10-24 04:20:06
[post_content] =>
[post_title] => epaper-83162-page-5-ad-83165
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => epaper-83162-page-5-ad-83165
[to_ping] =>
[pinged] =>
[post_modified] => 2024-10-24 04:20:06
[post_modified_gmt] => 2024-10-24 04:20:06
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://e.dental-tribune.com/ad/epaper-83162-page-5-ad/
[menu_order] => 0
[post_type] => ad
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[id] => 83165
[id_hash] => 4f07c1bf56927d5730c4f040b155ef1d3eefe0ff4cfbe6f33cd4ed656a30f6ef
[post_type] => ad
[post_date] => 2024-10-24 04:20:06
[fields] => Array
(
[url] => https://de.dental-tribune.com/c/amann-girrbach-ag/
[link] => URL
)
[permalink] => https://e.dental-tribune.com/ad/epaper-83162-page-5-ad-83165/
[post_title] => epaper-83162-page-5-ad-83165
[post_status] => publish
[position] => 0.22371364653244,0.31298904538341,99.552572706935,99.530516431925
[belongs_to_epaper] => 83162
[page] => 5
[cached] => false
)
)
[html_content] =>
)
[6] => Array
(
[image_url] => Array
(
[2000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/83162-8d448724/2000/page-5.jpg
[1000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/83162-8d448724/1000/page-5.jpg
[200] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/83162-8d448724/200/page-5.jpg
)
[key] => Array
(
[2000] => 83162-8d448724/2000/page-5.jpg
[1000] => 83162-8d448724/1000/page-5.jpg
[200] => 83162-8d448724/200/page-5.jpg
)
[ads] => Array
(
)
[html_content] =>
)
[7] => Array
(
[image_url] => Array
(
[2000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/83162-8d448724/2000/page-6.jpg
[1000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/83162-8d448724/1000/page-6.jpg
[200] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/83162-8d448724/200/page-6.jpg
)
[key] => Array
(
[2000] => 83162-8d448724/2000/page-6.jpg
[1000] => 83162-8d448724/1000/page-6.jpg
[200] => 83162-8d448724/200/page-6.jpg
)
[ads] => Array
(
)
[html_content] =>
)
[8] => Array
(
[image_url] => Array
(
[2000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/83162-8d448724/2000/page-7.jpg
[1000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/83162-8d448724/1000/page-7.jpg
[200] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/83162-8d448724/200/page-7.jpg
)
[key] => Array
(
[2000] => 83162-8d448724/2000/page-7.jpg
[1000] => 83162-8d448724/1000/page-7.jpg
[200] => 83162-8d448724/200/page-7.jpg
)
[ads] => Array
(
)
[html_content] =>
)
[9] => Array
(
[image_url] => Array
(
[2000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/83162-8d448724/2000/page-8.jpg
[1000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/83162-8d448724/1000/page-8.jpg
[200] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/83162-8d448724/200/page-8.jpg
)
[key] => Array
(
[2000] => 83162-8d448724/2000/page-8.jpg
[1000] => 83162-8d448724/1000/page-8.jpg
[200] => 83162-8d448724/200/page-8.jpg
)
[ads] => Array
(
)
[html_content] =>
)
[10] => Array
(
[image_url] => Array
(
[2000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/83162-8d448724/2000/page-9.jpg
[1000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/83162-8d448724/1000/page-9.jpg
[200] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/83162-8d448724/200/page-9.jpg
)
[key] => Array
(
[2000] => 83162-8d448724/2000/page-9.jpg
[1000] => 83162-8d448724/1000/page-9.jpg
[200] => 83162-8d448724/200/page-9.jpg
)
[ads] => Array
(
)
[html_content] =>
)
[11] => Array
(
[image_url] => Array
(
[2000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/83162-8d448724/2000/page-10.jpg
[1000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/83162-8d448724/1000/page-10.jpg
[200] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/83162-8d448724/200/page-10.jpg
)
[key] => Array
(
[2000] => 83162-8d448724/2000/page-10.jpg
[1000] => 83162-8d448724/1000/page-10.jpg
[200] => 83162-8d448724/200/page-10.jpg
)
[ads] => Array
(
)
[html_content] =>
)
[12] => Array
(
[image_url] => Array
(
[2000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/83162-8d448724/2000/page-11.jpg
[1000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/83162-8d448724/1000/page-11.jpg
[200] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/83162-8d448724/200/page-11.jpg
)
[key] => Array
(
[2000] => 83162-8d448724/2000/page-11.jpg
[1000] => 83162-8d448724/1000/page-11.jpg
[200] => 83162-8d448724/200/page-11.jpg
)
[ads] => Array
(
)
[html_content] =>
)
[13] => Array
(
[image_url] => Array
(
[2000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/83162-8d448724/2000/page-12.jpg
[1000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/83162-8d448724/1000/page-12.jpg
[200] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/83162-8d448724/200/page-12.jpg
)
[key] => Array
(
[2000] => 83162-8d448724/2000/page-12.jpg
[1000] => 83162-8d448724/1000/page-12.jpg
[200] => 83162-8d448724/200/page-12.jpg
)
[ads] => Array
(
[0] => Array
(
[post_data] => WP_Post Object
(
[ID] => 83166
[post_author] => 0
[post_date] => 2024-10-24 04:20:06
[post_date_gmt] => 2024-10-24 04:20:06
[post_content] =>
[post_title] => epaper-83162-page-13-ad-83166
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => epaper-83162-page-13-ad-83166
[to_ping] =>
[pinged] =>
[post_modified] => 2024-10-24 04:20:06
[post_modified_gmt] => 2024-10-24 04:20:06
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://e.dental-tribune.com/ad/epaper-83162-page-13-ad/
[menu_order] => 0
[post_type] => ad
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[id] => 83166
[id_hash] => 410138bd7b5f68c57416e2c4fb780e1bd42682f7a8f24efaf3e9dbfa21436c19
[post_type] => ad
[post_date] => 2024-10-24 04:20:06
[fields] => Array
(
[url] => https://www.dtstudyclub.com
[link] => URL
)
[permalink] => https://e.dental-tribune.com/ad/epaper-83162-page-13-ad-83166/
[post_title] => epaper-83162-page-13-ad-83166
[post_status] => publish
[position] => 1.5659955257271,50.860719874804,98.21029082774,48.982785602504
[belongs_to_epaper] => 83162
[page] => 13
[cached] => false
)
)
[html_content] =>
)
[14] => Array
(
[image_url] => Array
(
[2000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/83162-8d448724/2000/page-13.jpg
[1000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/83162-8d448724/1000/page-13.jpg
[200] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/83162-8d448724/200/page-13.jpg
)
[key] => Array
(
[2000] => 83162-8d448724/2000/page-13.jpg
[1000] => 83162-8d448724/1000/page-13.jpg
[200] => 83162-8d448724/200/page-13.jpg
)
[ads] => Array
(
)
[html_content] =>
)
[15] => Array
(
[image_url] => Array
(
[2000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/83162-8d448724/2000/page-14.jpg
[1000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/83162-8d448724/1000/page-14.jpg
[200] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/83162-8d448724/200/page-14.jpg
)
[key] => Array
(
[2000] => 83162-8d448724/2000/page-14.jpg
[1000] => 83162-8d448724/1000/page-14.jpg
[200] => 83162-8d448724/200/page-14.jpg
)
[ads] => Array
(
)
[html_content] =>
)
[16] => Array
(
[image_url] => Array
(
[2000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/83162-8d448724/2000/page-15.jpg
[1000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/83162-8d448724/1000/page-15.jpg
[200] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/83162-8d448724/200/page-15.jpg
)
[key] => Array
(
[2000] => 83162-8d448724/2000/page-15.jpg
[1000] => 83162-8d448724/1000/page-15.jpg
[200] => 83162-8d448724/200/page-15.jpg
)
[ads] => Array
(
)
[html_content] =>
)
)
[pdf_filetime] => 1729743606
[s3_key] => 83162-8d448724
[pdf] => today at IDS 2021 Show Preview (English).pdf
[pdf_location_url] => https://e.dental-tribune.com/tmp/dental-tribune-com/83162/today at IDS 2021 Show Preview (English).pdf
[pdf_location_local] => /var/www/vhosts/e.dental-tribune.com/httpdocs/tmp/dental-tribune-com/83162/today at IDS 2021 Show Preview (English).pdf
[should_regen_pages] => 1
[pdf_url] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/83162-8d448724/epaper.pdf
[pages_text] => Array
(
[1] =>
SHOW
PREVIEW
39th International Dental Show • Cologne • 22–25 September 2021
Interview
Industry trends
Products in focus
Mark Stephen Pace speaks about the innovations at IDS 2021 and major topics that
are shaping dentistry.
Learn more about state-of-the-art technology that will be on display during IDS 2021.
From direct restoration systems to handpieces and CAD/CAM software: this year’s
exhibitors have it all.
»2
»6
» 10
The show must go on—dental industry looks ahead confidently
IDS will help revive market situation after significant turnover decline in 2020.
“Digitalisation helps us
become more efficient,
improve communication and reduce costs,
© Koelnmesse/IDS
but it is no substitute.”
European press conference, from left to right: Dr Peter Engel, former president of the German dental association; Dominik Kruchen, president of the
association of German dental technicians’ guilds; Dr Marco Landi, president of the Council of European Dentists; Corinna Mühlhausen, Zukunftsinstitut Frankfurt; Mark Stephen Pace, Association of the German Dental Industry (VDDI) chairman; Oliver Frese, chief operating officer of Koelnmesse;
moderator Nadja Cleven; and Dr Markus Heibach, executive director of VDDI. (Image: Koelnmesse/IDS)
Mark Stephen Pace, VDDI
sales levels, the survey also indicated
that the industry would most likely
experience a recovery throughout
the course of this year. Over 50% of
the surveyed companies forecast an
increase in turnover in 2021, and an
additional 42% expected at least a
turnover at the level of 2020.
“Not all regions will recover at
the same pace. Some economic regions are still occupied with overcoming the corona crisis. The health
systems are under a high degree of
pressure, but we can assume that in
site events and sections that will
take place online. According to Dr
Peter Engel, former president of the
German dental association, and
Dominik Kruchen, president of the
Verband Deutscher ZahntechnikerInnungen (association of German
dental technicians’ guilds), these
concepts have already yielded positive experiences. They have found
that dentists are able to get used to
the new concepts relatively quickly
owing to their affinity for technology
and their openness. Nevertheless,
is very important that we maintain
relationships. The most important
part of successful business is not
possible without face-to-face meetings. Digitalisation helps us become
more efficient, improve communication and reduce costs, but it is no
substitute.”
Dr Marco Landi, president of the
Council of European Dentists, agreed
and then summed up by stating that
September is the right time to take
off again in the dental industry
across Europe.
Although some major players
in the dental industry, including
Dentsply Sirona, will not be taking
© Koelnmesse/IDS
€4.82 billion in 2020, 13.1% less than
2019. About €2.92 billion, a drop of
16.5%, was earned in export markets.
The German domestic market
however developed considerably
more robustly than the export markets. In 2020, domestic sales reached
€1.9 billion and were thus only 7.3%
lower compared with the previous
year. Overall, slightly more than twothirds of the companies that took
part in the survey reported lower
domestic sales figures than in 2019.
© Koelnmesse/IDS
In preparation for this year’s IDS,
the organisers held a live online
press conference via YouTube in May
to inform international media partners about the upcoming event. A
unique mix of analogue and digital
formats is planned for the event and
will make IDS 2021 a very special
event that will meet the demands of
this extraordinary time.
The press conference was held
under the motto “Out of crisis management and into future orientation”,
which will also be the motto of the
39th IDS, which will take place from
22 to 25 September in Cologne.
Mark Stephen Pace, chairman of
the board of the Association of the
German Dental Industry (VDDI), said
that everyone was looking forward to
the event. There was great optimism,
mainly because “developments are
going quite well”, “measures are having an effect”, and “vaccination successes are increasing worldwide”.
Pace explained why the implementation of the IDS is so important,
arguing that it is important for the
dental profession to have access to innovations and to be able to talk about
them. As an example, he mentioned
topics such as artificial intelligence,
which is progressing despite the pandemic, and which must be discussed.
He further emphasised that he and
the business organisation remain
Oliver Frese, chief operating officer of Koelnmesse, stated that the security concept implemented by
Koelnmesse will keep visitors safe and ensure that exhibitors are successful. (Image: Koelnmesse/IDS)
confident about the future economic
position of dental companies despite
a significant decline in turnover in
the 2020 fiscal year.
According to a Treuhand trust
survey that was launched at the beginning of 2021, the VDDI member
companies earned a total turnover of
Pace stated that, by implementing measures to increase efficiency
and reduce costs, dental companies
had done their utmost to ensure that
declines in sales did not escalate.
Although Pace assumed that
some companies would keep struggling for some time to reach 2019
the medium term the success of vaccinations will also lead to recoveries
in these regions. The general health
awareness and a need for health services resulting from this will increase,” Pace concluded.
The 39th IDS will be a hybrid
event—that is, a combination of on-
“people also want to meet in person,”
Kruchen added.
Pace reiterated the importance
of digitalisation and that progress
had been made, but stated that there
is clearly a lack of infrastructure to
move forward. He also feels it is essential to meet in person and said: “It
part in this year’s IDS for “various
reasons”, the organisers hope that
an interesting trade fair can be created with the companies that have
registered so far.
The latest information on IDS
can be found at www.english.idscologne.de.
[2] =>
news
SHOW
PREVIEW
“IDS will light the way for the whole dental industry”
An interview with Mark Stephen Pace, chairman of the Association of the German Dental Industry, ahead of IDS 2021 by Christian Ehrensberger.
For me, the first priority is to assess the situation and be proactive.
Patients come into the dental practice
with a greater awareness of health
and its various dimensions. Many patients now understand that oral
health and general health are closely
linked and that strengthening periodontal health is also a protective factor against severe progression of
COVID-19. While this has been reliably proved in studies, reduction of
other oral inflammation—for example
of the dental pulp—through treatment is also a likely advantage for
general health. Presumably, this is
also a positive component in the defence against COVID-19.
We can take advantage of this increased awareness in patients by discussing the subject with them and using it to create awareness of the
importance of recall appointments, as
well as the value of high-quality dentistry.
Mark Stephen Pace, chairman of the Association of the German Dental Industry. (Image:
DENTAURUM/Andreas Fabry)
n From 22 to 25 September, Cologne
will once more become the place to
be for dental professionals when the
39th edition of IDS takes place. Mark
Stephen Pace, chairman of the Association of the German Dental Industry, discussed his optimism ahead of
the event and the innovations that
he sees as drivers of the dental industry’s future.
Mr Pace, IDS 2021 is just around the
corner. Are you worried that another
COVID-19 wave will still prevent the
trade fair from taking place?
I think we have two options. Either we assume that IDS cannot take
place under any circumstances and
slide into depression, or we accept
the challenge and ask ourselves:
what do we have to do to ensure IDS
2021 will be a success for all involved
and lead our industry into a new normal? I have unequivocally decided in
favour of this second option.
With IDS only a few weeks away,
we can sense the promise of a new
beginning. IDS will light the way for
the whole dental industry!
What steps have you taken to make
IDS 2021 a success?
We have created safe conditions
in the trade fair halls. The #B-SAFE4business concept has been specifically developed for this purpose and
gives us great flexibility. If, for example, the minimum social distancing
requirements are decreased or increased the day before the trade fair
begins owing to the COVID-19 incidence rate at the time, we can react
immediately to the situation. Visitor
management will then also change
accordingly. This will be conducted
via our indoor positioning system,
developed in conjunction with Sam-
2
sung SDS, using the associated
eGuard smartphone app.
We must, of course, acknowledge
that we cannot prevent unexpected
developments related to the COVID-19
incidence rate in the broader population. Anything that occurs under the
present conditions over the next few
weeks will see us go as far as humanly possible to find a solution for
the trade fair. IDS 2021 will be a safe
place, not least because visitors from
industry and trade, and dentists, dental technicians and their teams deal
professionally with hygiene and infection control on a daily basis—and
thus will also do so at IDS.
What do you see as the major topics
that are shaping dentistry?
We have all certainly endured
some difficult months, but are now realising that it’s going to be different
in the future—things are looking up.
We must, however, also reorientate
ourselves and adjust to these new
conditions.
39th International Dental Show 2021
dustry forward the most—perhaps
self-regenerating teeth?
IDS always offers surprises
as far as innovation is concerned.
Self-generating teeth are unfortunately still the domain of sharks, but
innovative concepts for single-tooth
restoration of implants using digitally
What does this mean for IDS visitors?
As a trade fair visitor, I would
look around to see how I can offer patients the best possible dental treatment using state-of-the-art technology. This begins with periodontal
prophylaxis—virtually nowhere else
can you find such a large selection of
manual instruments, sonic and ultrasonic instruments, and powder–
water jets. At the same time, information will be available regarding adjuvant measures such as the administration of chlorhexidine and laser
treatments. At the trade fair, dentists
and dental assistants will also find
products that can provide maximum
protection of or relief for their tendons, ligaments and joints.
Similarly, with regard to oral inflammation, IDS 2021 offers attendees
the opportunity to test and compare
proven and innovative procedures
and products. To mention just one interesting detail: during diagnosis of irreversible pulpitis using analysis of inflammatory markers, it can emerge
that the tooth can still be retained vitally through pulp capping with bioactive or bactericidal material. This approach would probably be employed
more often with wider availability of
the analytic test procedure.
At previous IDSs, the focus has commonly been on digital technology.
Proven and innovative products, both small and large, aid in daily dental routines—and will be
available at IDS 2021. (Image: Koelnmesse/Thomas Klerx)
Where is the development of digital
technology headed?
Digital technologies have, in general, maintained their momentum
over the course of the pandemic, and
the dental industry remains a leader
in this regard. In attending this year’s
IDS, both dentists and dental techni-
CAD/CAM fabrication will be a focal topic of IDS 2021. (Images: Koelnmesse/Harald Fleissner)
cians are likely to have the following
two questions in mind:
1. What can be digitised in my dental
practice or laboratory so that I can
offer patients added value at a fair
and considered price?
2. What areas can utilise combined
analogue and digital procedures
as an alternative to complete digitisation? For example, a complete denture can either be completely 3D-printed or be set up
conventionally on a printed or
milled denture base with artificial alveoli and retained using an
adhesive in the final stage.
You have already discussed various
fields of innovation. What innovation
at IDS 2021 will help to take the in-
supported backward planning, however, is something I can very much
picture. Innovations that can be implemented immediately in the dental
practice and laboratory will also be
present at IDS 2021.
The biggest innovation for me,
though, is a new sense of togetherness. I experienced this already at
the European press conference in
the run-up to IDS 2021, and at the
event itself, we are coming together
again. We will be talking to each
other and actively looking for competition to ensure that we can secure the best deals. Personally, I’m
curious to see what interests dentists and dental technicians most,
and I wish everyone a safe and exciting IDS 2021. 7
[3] =>
[4] =>
news
SHOW
PREVIEW
EU wakes up to new medical device regulations
n After a three-year transition period and a delay of 12 months owing
to the SARS-CoV-2 pandemic, new
regulations for medical devices for
human use in the European Union
went into force on 26 May. The new
and stricter rules mainly apply to
those who manufacture, import and
sell medical devices; however, dental professionals should be aware
that distributors must keep a register of any complaints or reports received from health professionals
and patients relating to devices and
forward these complaints to the device manufacturer or importer.
Commonly referred to as the
MDR (Medical Device Regulation),
Council Regulation (EU) 2017/745
came into effect on 25 May 2017 with
a grace period of three years. The
MDR repealed Council Directive
93/42/EEC, known as the Medical
Device Directive (MDD), and Council
Directive 90/385/EEC, which regulated active implantable medical
devices in the EU. An additional directive—Council Regulation (EU)
2017/746, known as the In Vitro Diagnostic Regulation (IVDR)—came
into effect in tandem with the MDR
and is set to regulate in vitro diagnostic medical devices when a five-year
© symbiot/Shutterstock.com
What will change under the EU’s new medical device regulations?
transition period expires in May
2022.
The European Commission, in
April last year, announced a 12-month
delay of the application of the MDR.
A statement from the commission
explained that the decision was
made so that member states, health
institutions and commercial operators in the medical devices industry
could prioritise efforts to combat
the pandemic. “Shortages or delays
in getting key medical devices certified and on the market are not an
option right now,” commented Mar-
garitis Schinas, vice president for
promoting our European way of life,
in the media release. Indeed, the
MDR is denser and more complex
than its predecessor and transposing the directive has been a mammoth task for all stakeholders.
Compared with the repealed
MDD, the MDR changes device
scope and the way that medical devices are classified. For example, the
legislation includes new rules for devices that use hazardous substances
and for software applications. Some
devices have been reclassified under
IDSconnect: The new digital
event platform of IDS
Koelnmesse has stepped up its game to make IDS a successful event—online and offline.
live from Cologne or streaming from locations throughout the world. The IDS Main Stage is the central platform
for the official event programme of IDS 2021. This
is where to find insight and motivation in the many
presentations and official side events. Let yourself be
inspired by the visionary programme.
The area Exhibitors and Products represents the
exhibition hall. From there, users have access to the
booths of the various exhibitors in so-called Showrooms in which relevant information about the exhibitor’s company, products and services will be provided.
On the Product Stage, exhibitors will present product
effects of any current deficit in these crucial elements.
Extensive features enable you to reach more potential
customers easily, to experience trends and lectures on
demand, and to establish valuable contacts—from anywhere in the world.
The experience starts in the Lobby, where users find
an overview of all the features as well as initial recommendations for relevant contacts, exhibitors and upcoming scheduled trade fair items. Features include top
experts on stage presenting on industry-relevant topics
innovations and highlights live to the audience. Alter
natively, these can be watched later on demand.
At a Virtual Café, visitors, exhibitors, top decision
makers, purchasers, industry experts and media representatives can come together to chat and network.
In terms of networking, the Discovery Graph ensures
networking with new contacts and achieving a direct
exchange of ideas via the communication centre.
More information about IDSconnect can be accessed at
https://www.english.ids-cologne.de/fair/idsconnect/. 7
© Koelnmesse
n In 2021, IDS is going hybrid, which means that more
participants than ever before will attend the largest
trade show in the dental industry from the comfort of
their homes and not in person, owing to COVID-19 travel
restrictions. To provide a digital enhancement to the
classic physical event, the free platform IDSconnect
intends to maintain IDS’s extensive international reach
together with a successful on-site trade fair experience.
At a trade fair or in day-to-day commercial business,
a company’s success is based on three essential building
blocks: inspiration, interaction and business. IDSconnect
provides innovative opportunities for you to reduce the
4
39th International Dental Show 2021
the MDR, and the directive regulates
certain devices that were previously
exempt from medical device regulations.
The MDR also brings changes to
the oversight process. Under the
new directive, only notified bodies
that are designated under the MDR
can verify medical devices as being
fit for use in the EU. Notified bodies
that were designated under the
MDD must be newly designated under the MDR. According to a white
paper published by the Brussels-
based European business law firm
contrast and the Association of Dental Dealers in Europe—seen by Dental Tribune International—the public
health situation in Europe has hampered efforts to designate enough
notified bodies. Since some notified
bodies that were designated under
the MDD may not receive designation under the MDR, it is expected
that some medical device manufacturers will need to change notified
bodies.
Other examples of the various
changes brought by the MDR include a redefined economic operator
concept, which differentiates between manufacturer, authorised representative, importer and distribu-
tor. All economic operators must
conform to the directive and the responsibilities of these stakeholders
are expected to increase.
The MDR also brings heightened
post-market surveillance to the medical devices market, and EU member
states are required to adopt penalties for any infringements of its requirements. Unique identifiers must
be placed on medical devices so that
they can be registered on a new European database. Named EUDAMED,
the database will record the registration of devices, the accredited notified bodies, and also certificates and
reports of incidents relating to the
safety and clinical performance of
devices.
Distributors will be required to
keep a record of any complaints or
reports that they receive from
health professionals and immediately forward them to the manufacturer and/or importer of the device
in question. Distributors of medical
devices must also keep a register of
non-conforming devices and devices
that were recalled or withdrawn
from sale.
The full text of the MDR is available at https://eur-lex.europa.eu/eli/
reg/2017/745/oj. 7
Around 830 exhibitors
from 56 countries to
attend IDS 2021
High number of international companies underscores importance
of global industry platform.
n The International Dental Show
(IDS) will be opening its doors for the
39th time from 22 to 25 September.
Owing to the ongoing global SARSCoV-2 pandemic, which led the or
ganisers to postpone the event from
March to September, this year’s edition will be taking place under
extraordinary circumstances. Although a considerable number of
companies will not be exhibiting at
IDS, about 830 companies have already confirmed their participation.
According to the latest figures by
Koelnmesse, 74% of exhibitors come
from abroad, including from France,
Great Britain, Italy, South Korea,
Switzerland and the US. Companies
from Brazil, Bulgaria, China, France,
Italy, South Korea, Russia and the
US will have country-specific pavilions. In a recent press release, Koelnmesse stated that the high level of international participation underlines
once again the outstanding significance of IDS as the most important
global dental industry platform.
Overall, the organisers predict
that IDS will play a key role in the
successful restart of the market.
Throughout 2020, dental companies
around the globe reported the financial effects of government-imposed
lockdowns and radical public health
measures, including the partial or
complete closure of dental practices.
As revealed by the fourth-quarter re-
sults for 2020 and this year’s first-
quarter results, the industry is slowly
but steadily recovering from the crisis.
In order to protect and ensure the
health and safety of exhibitors and
visitors alike, rigorous protective
measures in line with the official requirements have been taken into
account in the allocation of the exhibition floor. IDS 2021 will be staged
in Halls 2, 3, 10 and 11, which are
connected via a simple circular route.
Visitors will be able to enter the fair
through four entrances, which will
allow for an even distribution of attendees across the exhibition halls.
To meet social distancing rules, the
existing restaurant and resting areas
in the halls have been expanded and
a new food area has been installed in
Hall 4.1.
In addition, the organisers are
extending the physical event in Cologne through the digital platform
IDSconnect. This strategic move to
make IDS 2021 a hybrid event will
benefit both dental professionals and
companies and, in particular, those
who will not be able to travel to Cologne in September, as it includes a
number of innovative features that
will allow users to discover new products and connect with colleagues and
partners online. More information
about IDS can be found on the https://
www.english.ids-cologne.de/. 7
[5] =>
FOR DIGITAL TEAMPLAYERS.
PATIENT
CASE SHARING
20
min
HIG
www.ceramill-drs.com
22-25 September 2021
2021 Hall 3.2 | Booth A010–B011
H-SPEE
D
Amann Girrbach AG | Tel +49 7231 957-100
Tel International: +43 5523 62333-390
www.amanngirrbach.com
Available exclusively in selected markets for the time being.
Interested parties outside Germany please contact the responsible Amann Girrbach dealer.
HIGH-SPEED ZIRCONIA KIT
NTERING
PRODUCTION KIT
SI
CONNECTION KIT
[6] =>
news
SHOW
PREVIEW
For patients looking for high-quality dentistry, IDS provides the answers
An overview of the state-of-the-art technology on exhibit at IDS 2021 by Christian Ehrensberger.
1
2
3
The whole range of filling treatments at the world’s leading dental trade fair: Some of the goal-oriented and attractive solutions for dental practices from
Silfradent, Polydentia and GC that will be on display at IDS 2021. (Images: Koelnmesse/IDS Cologne/Harald Fleissner [1 & 2]/Thomas Klerx [3])
n The development of dental prac
tices is in a much better position than
one and a half years ago, and the
COVID-19 pandemic is even show
ing positive signs. The 2021 IDS in
Cologne will provide a view into
where we are headed.
Oral health: A key theme and
an opportunity for the dental
practice
Broad segments of the population
are becoming increasingly interested
in health, nutrition, physical activity,
sport, medicine and more. This has
resulted in a particularly strong focus
on dentistry, since many patients are
becoming aware of the significance
of the oral cavity for their general
health, including preventing the se
vere progression of COVID-19.
This is boosting patients’ confi
dence in their dental team, in their
expert consultation skills and in their
ability to perform prophylactic treat
ment. Among other things, hygiene
standards are contributing to this.
This is a classic core competence of
the dental practice—though there are
still things that can be improved.
Based on current studies, optimising
the holding technique for suction and
a demand-oriented design of the suc
tion system will further improve
existing hygiene standards. Impor
tant decisions are made in particular
when founding, taking over or ex
panding a dental practice. IDS 2021
4
A way to control the viscosity of a bulk fill composite from flowable to mouldable: thermo-viscous
material for the entire Class I, II and V indication range (VisCalor bulk, VOCO). (Image: Koeln
messe/IDS Cologne/Thomas Klerx)
6
39th International Dental Show 2021
will provide an overview of suction
systems and suction tips, and visitors
will be able to experience first-hand
how the responsible design of their
dental treatment facilities can pro
vide the ideal hygienic conditions for
the use of the entire range of instru
ments. This includes, in particular,
high-speed turbines and powder–wa
ter jets used in prophylaxis.
(2) compatibility; (3) preservation of
as much natural tooth structure as
possible; (4) natural aesthetics; and
(5) favourable price. IDS 2021 allows
a comparison of current filling mate
rials in line with these criteria.
At the same time, the trends to
wards speeding up and simplifying
the clinical procedures are continu
ing. The team can now work more
quickly with many of the numerous
self-adhesive composites. A compari
son of the achievable adhesion val
ues and marginal impermeabilities
with the corresponding values of
classic three-step etch and rinse sys
tems as a reference shows how far
their indication now extends.
Bulk fill composites can be ap
plied in cavities in layers that are
4–5 mm thick, thus avoiding a time-
consuming incremental technique.
Flowable bulk fill composites are
then overlaid with an occlusal filling
material, and with specialist prod
ucts, a change in consistency can
be induced by sonic activation. For
example, these are flowable when
placed and become mouldable later.
With this procedure, as with the
high-viscosity bulk fill composites, a
covering layer may be omitted.
The existing range of composites
is further enriched by dual-polymer
ising and permanent composite rela
tives. Able to be used without reten
tive preparation and without etching,
bonding or other conditioning, these
materials allow for a tooth-coloured
restoration and can be placed in the
cavity quickly. However, a different
technique is required.
improvement of nickel–titanium al
loys for files has reached a level
where innovative clinical concepts
allowing for the conservation of tooth
structure are now possible. At the
same time, digitally supported endo
dontic backward planning is becom
ing established and, with it, new
forms of collaborative working. For
example, the dental practitioner can
have specialists perform the digital
planning (including files, obturation
and an endodontic drilling template
for the access cavity), but perform the
subsequent treatment himself or her
self.
Backward planning in implantol
ogy is already part of the standard
repertoire, and new digital interfaces
that allow for a truly integrated digi
tal workflow will be presented at IDS
2021. Furthermore, the benefits of
the use of artificial intelligence (AI)
are already becoming tangible. It is
hoped that AI will provide ever
greater assistance in the evaluation
of radiographic images and other
visual representations.
Attendees will also be able to ex
perience innovation in orthodontics.
The classic means of checking for oc
clusal contact is now supplemented
by digitally supported variants, and
special bruxism splints can even pro
vide immediate biofeedback and thus,
ultimately, help prevent damage.
The sheer range of proven and in
novative products, enabling patients
to be treated using state-of-the-art
technology, that will be on display at
IDS 2021 is unique. Visitors to the
trade fair will also develop a keen
Filling treatments will
become more customised,
quicker and easier
In the future, patients in all areas
are likely to attach greater impor
tance to extremely high-quality res
torations. For example, they will
want restorations that are hygienic
as well as increasingly highly aes
thetic.
Direct restorations have been
an outstanding and innovative field
for years. Since they represent the
bread and butter of the vast majority
of practices, even minor advances in
procedures and materials have a
clearly positive impact.
The dental team works with a
number of proven materials, includ
ing composites, compomers, glass
ionomer cements and amalgam, still.
Recently, composite hybrids have
been added to this mix. The field of
dental materials is becoming more
differentiated, and so in a given clin
ical situation, a decision can be made
in favour of different options. Pa
tients come to the dental practice
with specific wishes and set their
preferences accordingly. In general,
this list of preferences can be as
sumed to be (1) long-term stability;
5
At IDS 2021, new interfaces will turn various well-functioning partial workflows into a fluid, fully
digital procedure from A to Z. (Image: Koelnmesse/IDS Cologne/Harald Fleissner)
Digital processes: Strong
in specialist disciplines
In endodontics, the trend is in
creasingly towards conserving more
natural tooth structure. The gradual
sense of how patients with their
clearly increased interest in health in
general and dental health in particu
lar can best be persuaded to visit the
dental practice. 7
[7] =>
news
SHOW
PREVIEW
The growing localisation of trade fairs
An opinion piece by Björn Kempe.
We are almost in the fourth quarter
of 2021 in the second year of the pandemic. What has changed so far in the
German and international exhibition
market worldwide, and what are the
prospects for the future? These are
the questions I hear almost every
week through my social media channels or from friends. My answer to
this is relatively simple.
In the 18 months of the pandemic, almost nothing has changed
in the trade show market. The only
thing that has changed—especially
in Germany—is the urge to digitise
faster. However, the first virtual and
hybrid German trade shows have
shown that one cannot make money
with them so far, and only about
20 —25 % of attendees are excited
about them. Additionally, an average
of 30% of employees of trade fair companies have been cut, short-time
work is still prevalent, and many
highly qualified and long-serving employees have left the business for reorientation.
Apart from digitisation measures and staff cutbacks, nothing
new has emerged in almost two
years except for cancelled or postponed shows. Personally, I do not
think this approach will be enough
in the long run. Much more could
have been done in 2020 and 2021.
The trade fair industries in China,
the UK and the US show that local
concepts can work perfectly. People
need trade fairs to network, get to
know each other and, most importantly, do business. This was under-estimated in Germany.
Not only was the time span of
the pandemic under-estimated but
also its effect on customers. Many
trade show organisers in Europe literally outbid each other at the end of
2020 and the beginning of 2021 for
hybrid and virtual concepts. What
is left is a virtual and hybrid exhibition market controlled by a few
event technology companies, like
Grip, Swapcard and Corussoft. Many
exhibition companies even took the
trouble to develop their own software and systems for a great deal of
money—unfortunately almost certainly a bad investment. Event technology programmes are easily available off the shelf, and Messe
München and Messe Düsseldorf are
showing with Grip that it is very
easy to use these without much programming and effort.
I would have liked to have seen
every trade fair in Germany launching its own new concepts this year—
local concepts that play a role for either the city or the region with a
maximum radius of 500 km. Looking at the Chinese or US market, one
can see that the local and regional
component plays a much greater
role than in Germany, which, for example, has only two medical technology trade fairs.
In the near future, I would like
to see new trade shows coming on to
the market—small and attractive. Organisers need to take a closer look at
their city’s industries and attendees’
needs. It is clear that there will not
be any decent big international
trade shows until 2024. The speed of
vaccination is too slow for that, and
countries are too diverse to agree
on global travel arrangements. Also
2022 will be a difficult year for our
industry, as only vaccinated and recovered persons will have unrestricted access to events and only
business-to-business travel will be
allowed within Europe. In the past,
Chinese pavilions took up over 30%
of exhibition space at some trade
shows, and other Asian countries
and the US are very important trade
show participants in Germany. This
will probably not happen again until the end of 2023. Thus, optimistically speaking, the next “normal”
trade fair year will commence in
2024. Until then, organisers should
not let the time pass! Think local,
create great trade fairs and don’t
invest too much money into digitisation and certainly not into your
own programming.
About
Björn Kempe is the founder and CEO
of Expos Asia, which is part of the
EXPOS Global network, headquartered in Singapore. His consulting firm
specialises in mergers and acquisitions, capital raising, investments,
business development consulting
and strategy consulting. Expos Asia
also organises its own events in
China and Indonesia.
The status of trade fairs in Germany
It is no secret that the 39th edition of the International Dental
Show (IDS) will look vastly different to previous iterations. The record 160,095 international visitors
that attended IDS 2019 will be greatly reduced owing to COVID-19
travel restrictions, though a hybrid
approach will mean more people
than ever will participate virtually
rather than in person. Nevertheless,
there remains a high level of demand for physical trade fairs to return and for Germany to re-establish itself as the international leader
in this field.
Let’s start with the good news.
Presently, a majority of the German
population has been fully vaccinated against COVID-19, significantly decreasing their likelihood of
developing a symptomatic form of
the disease. In addition, there exists
an undeniable appetite for in-person
trade fairs to return. A recent survey
of its customers conducted by Messe
Frankfurt, the world’s largest trade
fair organiser, found that 97% still
saw the in-person component as an
essential part of such events.
For those who do travel to Cologne for in-person participation, comprehensive hygiene protocols and
sanitation measures will be in place to
offer exhibitors and visitors a safe exhibition experience. The wearing of
face masks is mandatory, and people
with COVID-19 symptoms—coughing,
sniffles, loss of smell or taste, fever,
etc.—are not allowed to enter the exhibition grounds. In addition, Koelnmesse’s #B-SAFE4business concept—
which was demonstrated as a
prototype before the press late last
year—includes a comprehensive catalogue of protective hygiene measures
designed to reduce the risk of SARSCoV-2 transmission. Personalised tickets and contactless identity checks
and bag searches at the entrances will
be available, while trained personnel
will be present to ensure that all hygiene regulations can be easily observed and followed at each exhibitor’s booth. Visitors to IDS 2021 will
also be required to install the eGuard
mobile application, which is designed
to guide visitors so that they can best
avoid crowds and maintain appropriate social distancing.
Virtual participation a point
of emphasis
Of course, travel restrictions
and the limited availability of vaccines has meant that the Association of the German Dental Industry
(VDDI) and Koelnmesse—the joint
convenors of IDS—have had to make
some key changes to how IDS 2021
can be experienced by those who
cannot, or choose not to, attend in
person. Chief among these is a hybrid approach powered by the free
digital platform IDSconnect, which
the organisers hope will make IDS
2021 a successful event online as
well as offline.
“In tandem with the physical
exhibition, IDSconnect will offer information on products and system
solutions and will enable the streaming of webinars, press conferences,
events and one-to-one conversations
with clients,” Markus Oster, business unit manager of trade fair
management at Koelnmesse, told
DTI earlier this year. “This will facilitate a consistent international reach
combined with a successful trade
fair experience.”
© eldar nurkovic/Shutterstock.com
© Arnold O. A. Pinto/Shutterstock.com
A look at the current environment.
The road to recovery
Five of the top ten highest-grossing trade fair companies are headquartered in Germany, and it is important to note just how severe the
impact of the COVID-19 pandemic
has been on this industry. According
to the Association of the German
Trade Fair Industry (AUMA), just 114
of the 355 trade fairs planned in Germany in 2020 were able to take
place, and this year, the first in-person congress was only held in June.
The dearth of activity led to
many leading trade fair facilitators
suffering extensive financial losses,
and AUMA stated that overall trade
fair business in Germany fell by approximately 70% during 2020. Koelnmesse, for example, recorded a turnover of €94.3 million for the year—less
than a quarter of the €413 million it
generated in 2019. This, in turn, led
the company to declare a net loss of
€109.6 million for 2020, and it expects to incur sizeable losses once
more in 2021.
Though IDS 2021 is expected to
have around 830 companies from
over 56 countries exhibiting, there
are a number of notable absences
that will undoubtedly be felt. Stalwarts, including Dentsply Sirona,
Nobel Biocare and Ivoclar Vivadent,
have elected not to participate this
year. Walter Petersohn, chief commercial officer at Dentsply Sirona,
explained that a major factor for his
company’s withdrawal was the lack
of the “absolute planning certainty”
needed to prepare for such a show.
Regardless, there is a sense of
optimism that surrounds IDS 2021
and what its success could mean for
the future of trade fairs in Germany.
“Even if the first on-site trade
fairs do not have the same dimensions and level of global internationality as in the past, the main thing is
that we return to the scene as soon
as possible,” said Oliver Frese, chief
operating officer at Koelnmesse, at a
press conference in May.
“In recent months, we have been
even more dedicated than ever to
developing hybrid and digital trade
show experiences all the way
through to a year-round online presence for our trade fair brands,” he
added.
39th International Dental Show 2021
7
[8] =>
news
SHOW
PREVIEW
Top three trends influencing US dental bone grafting industry in 2021
US dental bone graft substitutes market size expected to reach $390 million in 2021.
competitive pressures, the mediumand long-term growth trends remain
positive. Major drivers of sales include
growth in the related dental implant
market, increases in supporting scientific literature, and innovations in dental regenerative products. Like the
dental implant market, the DBGS and
related biomaterial markets will make
a strong recovery from the pandemic-
induced market shock and continue a
modest growth trend over the forecast
period. 7
Editorial note: A list of references can be obtained from the publisher.
About the authors
The number of implants being placed with bone graft substitutes is increasing, and a growing body of evidence suggests that most dental implant procedures could benefit from a bone graft.
(All images: iData Research)
n Dental bone grafting has become
an important and common step in the
dental implant procedure. Advancements in allograft, xenograft and synthetic bone graft materials have positioned them as suitable alternatives to
traditional autologous bone grafts,
and this has created a thriving market for dental biomaterials. Although
demand declined significantly in
2020 owing to the rippling economic
effects of the COVID-19 pandemic, it
is expected to recover quickly alongside the overall demand for dental implants.
Notable trends accelerating
growth in this market include the increasing number of dental implant
procedures performed. There is also a
growing body of evidence suggesting
that most (if not all) dental implant
procedures could benefit from a bone
graft.1 Although the dental bone graft
substitute (DBGS) market faces some
minor headwinds in commoditisation
effects and short-term pandemic-
related constraints, the long-term outlook and secular growth trends remain positive.
Trend 1: Growth in implant
market; stronger scientific
support
The percentage of dental implants
placed with DBGS in the US is forecast
to grow from 58% in 2020 to over 60%
in 2027, according to iData Research’s
new report on the US DBGS market.
Because the two markets are closely
related, the same growth trends that
drive the demand for dental implants
will also contribute to growth in sales
of dental biomaterials. These trends include an aging population that is more
prone to ailments like edentulism, a
growing number of dentists trained in
implant dentistry, improved consumer
accessibility owing to industry consolidation, and stronger value propositions offered by shrewd pricing strategies.
8
In addition, there is growing clinical research suggesting that bone
graft substitutes perform as well as autologous grafts with regard to bone formation, eliminating the need for costly
and uncomfortable secondary grafting procedures.2 This level of rigorous
scientific documentation lends credence to manufacturers’ own clinical
trials and reinforces the value proposition of DBGS materials in implant dentistry.
Trend 2: Slowing innovation
and bundling of DBGS
Innovations in bone grafting products are most often driven by advancements in the much larger orthopaedic
market, before trickling down into
dental applications. In recent years, innovation has slowed in both the orthopaedic and dental biomaterial markets, particularly with regard to bone
graft substitutes, leaving little room
for price growth and product differentiation. Furthermore, parts of the market are heavily fractured owing to
hundreds of competitors offering similar products, which exerts downward
pressure on prices and market value.
Put together, the two effects
of commoditisation and bundling present a moderately bullish case for the DBGS market
Leading manufacturers have instead turned to leveraging their strong
positions in the marketplace by employing bundling strategies to mutually reinforce demand for both dental
implants and biomaterials. Because
demand for dental biomaterials is
largely driven by specialists, who
typically order large volumes of dental
implants in bulk, companies with
strong brand recognition across the
dental supply industry, like the
Straumann Group, Zimmer Biomet
and BioHorizons, have capitalised
on this imbalance by bundling DBGS
and implant products.
39th International Dental Show 2021
Put together, the two effects of
commoditisation and bundling present a moderately bullish case for the
DBGS market. Although competition
and commoditisation can threaten
stalled growth, strong players in the
DBGS and adjacent markets will be rewarded if they are able to continue
providing value to end users by offering attractive pricing strategies. The
DBGS overall sales value is expected
to have shrunk by nearly 21% in 2020
owing to the pandemic-induced economic downturn, followed by a sharp
rebound of around 22% in 2021.
Trend 3: Innovation opportunities in barrier membranes
and regenerative materials
While innovation in DBGS has
slowed, there is no evidence of this for
dental barrier membranes and dental
growth factors. Over the next six
years, both markets are projected to
grow at an annualised rate of over 6%,
following a sharp decline in 2020 and
a complete recovery in 2021.
In the barrier membrane supply
chain, market leader Osteogenics
Biomedical has been consistently releasing new products with promising
novel features. In 2019, the company
released the RPM reinforced PTFE
mesh, which was designed to work
like a traditional titanium mesh but
with a porous design that provides the
added benefits of easier trimming and
adaptation. In 2020, Osteogenics announced a distribution partnership
with DBGS giant Geistlich Pharma,
adding the mesh to Geistlich’s expansive biomaterial portfolio. This move
combines the brand recognition of two
strong players in their respective markets to reinforce demand.
Currently, manufacturing of dental growth factors is led by four major
players: Medtronic, Lynch Biologics,
the Straumann Group and ACE
Surgical. Each of these companies’ regenerative products is indicated for
a slightly different use, though they all
generally originated as innovative
products for orthopaedic applications.
Dental growth factor production is still
in its early stages of the industry life
cycle, and the entire market stands to
benefit from new product developments in the orthopaedic market. Furthermore, blood derivative growth factors such as platelet-rich fibrin (PRF)
are seeing a rise in popularity. Notably, BioHorizons acquired Intra-Lock
in 2018, stating in a press release
that it was “excited to add the
IntraSpin system to [its] portfolio since
[PRF] is increasingly used in grafting
procedures.”3 Although it is not yet
clear that blood derivative growth factors are ready for prime time, an endorsement of PRF products by a major
player is a good indication of the market trend.
Dr Kamran Zamanian is CEO and
founding partner of iData Research.
He has spent over 20 years wor
king in the market research industry
with a dedication to the study of
dental implants, dental bone graf
ting substitutes, prosthetics, as well
as other dental devices used in the
health of patients all over the globe.
The impact of COVID-19 on
dental bone graft substitutes
The COVID-19 pandemic and subsequent forced business closures
ground all dental implant procedures
to a halt in early 2020. As dental clinics across the US began to reopen in
the latter half of 2020, dentists reported a large volume of pent-up demand for implant (and therefore bone
grafting) procedures, which is a promising indicator for a strong recovery.4
Industry leaders remain confident in
their respective companies’ fundamentals and expect to recover pre-
pandemic sales by the end of 2021 or
early in 2022 before resuming pre
vious growth targets.
Demand is forecast to grow
Demand for dental biomaterials
will continue to grow alongside the
dental implant market for the foreseeable future in the US as well as in
21 other countries, as analysed by
iData Research. Although some segments may be negatively impacted by
slowed innovations and increased
William Guo is a research analyst at
iData Research. He has been invol
ved in the global research of dental
implant and bone graft substitute
markets, publishing the reports on
the US market.
About iData Research
For 16 years, iData Research has
been a strong advocate for data-dri
ven decision-making within the
global medical device, dental, and
pharmaceutical industries. By pro
viding custom research and consul
ting solutions, iData empowers its
clients to trust the source of data
and make important strategic deci
sions with confidence. More infor
mation: https://idataresearch.com
[9] =>
news
SHOW
PREVIEW
The pandemic continues to bite:
COVID-19 and the dental market
by Jeremy Booth
The latest earnings reports from major dental companies show that dental offices around the world are open and doing business, but that the market has not yet returned to 2019 levels. (Image: Mirror-Images/Shutterstock.com)
n Sales at major dental companies
climbed in the second quarter of
this year compared with the same
period in 2020, during which the
pandemic brought dentistry to a
grinding halt. In the latest series of
earnings reports, some dental company chiefs praised the recovery of
the market, whereas others outlined falling discretionary spending, concerns about SARS-CoV-2
variants and sluggish vaccine rollouts in some geographic areas.
David Katzman, CEO of tele-
orthodontics company SmileDirectClub (SDC), was candid when he
spoke with analysts in August. SDC
missed its earnings expectations for
the quarter. Katzman pointed to
SDC’s newest international markets,
Spain and Germany, where he said
“lingering effects” of the COVID-19
pandemic had hampered earnings.
He said that, at home in the US, the
company’s target demographic had
been hit hard in the pocket by the
health crisis.
He explained: “[Our] core demographic, which has a median household income of $68,000 (€58,000),
likely experienced outsized pressures in their capacity to spend on
discretionary items given the significant inflationary headwinds facing
the non-discretionary categories
like transportation, utilities and
food.”
SDC’s target consumers, Katzman said, appeared to be favouring
products over services owing to
pent-up demand for apparel, automobiles and home-related goods.
Joblessness was also having an impact. He explained: “Further contributing to the unfavourable condition
of constrained capacity on spend on
discretionary items and a general
consumer preference for products
over services, joblessness remains
pervasive in four of our larger states,
California, New York, Texas and
Florida. Through 10 July 2021, these
four states represent 40% of the
nation’s continuing jobless claims.”
Total sales revenue at SDC for
the quarter was $174.2 million, an
increase of 62.7% year over year, and
the company completed just over
90,000 unique aligner shipments,
compared with 57,136 in the second
quarter of last year. During the call
with analysts, Katzman detailed the
financial costs of a June cyber-attack
on the company and praised growing acceptance of tele-orthodontics.
Align Technology posts
$1 billion in sales
Staying with orthodontics, leading clear aligner maker Align Technology fared better than SDC during
the quarter, as it continued to break
its own earnings records. The company sold $841 million worth of
clear aligner trays during the period—
a year-over-year increase of 181.9%—
and its imaging systems and
CAD/CAM services revenue was
$169.8 million, a 214.7% year-overyear increase. Total sales therefore
topped $1 billion for the first time.
Compared with the first quarter of
this year, the company’s clear
aligner and imaging services revenue streams were up 11.6% and
20.0%, respectively. Clear aligner
volume for the second quarter increased by 200.0% year over year to
reach 665,600 cases, and clear
aligner volume for teenagers increased by 156.3% to reach 181,000
cases.
A look at the company’s regional
figures shows that dentists in most
regions provided Invisalign treatment to more patients in the second
quarter of this year than they did in
the quarterly periods before the pandemic. In the Americas region, case
volume was up 260.7% year over
year. International shipments were
up 149.2%, and those in the Europe,
Middle East and Africa region
(EMEA) were up 265%, led by Iberia,
the UK and Italy. In the Asia Pacific
region, clear aligner volume increased by 50%, led by Japan, China,
Australia and New Zealand.
Straumann remarks on
improved patient volumes
in 2021
The results of another international player, Straumann Group, will
give readers an impression of the state
of global dental markets. In the EMEA
region, total sales of CHF 230 million
(€212.7 million) represented a 102%
year-over-year increase, which Straumann credited to sales of premium
and challenger implant brands, its orthodontics business, and strong sales
in Germany, Iberia, France, the UK
and Turkey. Straumann’s organic sales
growth in North America decreased
by 42% during the second quarter of
2020; this year, it increased by 135% to
reach CHF 152 million. Sales in the
Asia Pacific region rebounded by 63%
in the period to reach CHF 103 million. In Latin America, where Brazil is
the largest contributor to regional revenue, CHF 31 million in sales represented a year-over-year increase of
174.4%.
Straumann’s total revenue for the
second quarter was CHF 516 million.
This represented a year-over-year increase of around 92%—in the comparable period last year, Straumann’s total
revenue of CHF 248 million was down
nearly 40%.
Straumann published a halfyearly report at the close of the second
quarter, and in the report, the company said that dental practices had
been operating with “healthy patient
flows throughout the first half of
2021”.
Straumann CEO Guillaume Daniellot reminded analysts in a conference call: “When we held our last media conference three months ago, our
industry was in lockdown. COVID-19
had cut our monthly revenue by 70%,
and we were initiating measures to
reduce our headcount and cost base
in preparation for the economic re
cession that the pandemic is expected
to trigger.” He added that the situation
on the day of the latest media conference (12 August 2021) was more po
sitive. “With the exception of Latin
America, which is still in the eye of the
storm, all of our regions report that
more than 85% of dental practices are
open. Correspondingly, between 85%
and 100% of our facilities are open and
our sales team are operating at similar
levels. In short, both we and our customers are back to business.”
Envista optimistic about
continued recovery
Sales at Envista Holdings in the
second quarter were $740.1 million,
an increase of 104.4% year over year.
The close of the period marked four
consecutive quarters of growth for
Envista’s premium implant business—
which achieved 90% core sales
growth in the three-month period
ended 30 June.
Envista CEO Amir Aghdaei said
during the company’s earnings call
that Envista had seen solid demand
for its infection prevention business,
owing to the fact that enhanced disinfection protocols are now the new normal. Aghdaei said: “We’re excited
about the opportunities for a new
CaviWipes 2.0 product. It features a
two-minute universal contact time,
shows efficacy against a broad range
of pathogens, including the COVID-19
virus, and increases our opportunity
to penetrate the medical market further while enhancing our dental position.”
Howard Yu, senior vice president
and chief financial officer at the company, said: “While patient volumes
have improved to pre-pandemic levels
in our major markets, we continue to
see inconsistent roll-outs of vaccines
and spikes in COVID-19 variant in
fections in several geographic areas,
including Western Europe and parts of
the United States. Overall, we are
mindful of the pandemic-related risks
but remain optimistic for a continued
recovery throughout the balance of
2021.”
Aghdaei added: “While vaccination rates are increasing every day, we
are mindful of the risk related to
COVID-19 variance, continue to moni-
tor reopening of economies and acknowledge that vaccination rollout
worldwide [is] at different stages. However, we believe that patient demand
will sustain at pre-pandemic levels,
due to the industry’s enhanced sani
tation measures.”
Envista owns more than 30 dental
brands, including major names like
KaVo Kerr, Nobel Biocare and Ormco.
Dentsply Sirona cautions over
“ongoing impact”
Net sales at Dentsply Sirona for
the second quarter were $1.067 billion, a 117.3% year-over-year increase.
In the dental consumables segment,
net sales of $445 million for the period
represented a 138.0% increase. Sales
of dental technology and equipment
reached $622 million, a year-over-year
gain of 104.6%.
US sales were $366 million, up
179.4% year over year, European sales
of $431 million were up 99.5%, and
sales in all other markets reached
$270 million, an increase of 87.5%.
In a call with analysts, Jorge M.
Gomez, executive vice president and
chief financial officer at the company,
commented: “Growth was strong
across all regions and in all categories,
most notably within the endo and [restorative] parts of our portfolio, which
represent strategic priorities for our
business.”
CEO Donald M. Casey said that
the dental market continues to recover
and to demonstrate its underlying resilience, but that dentistry is not yet
out of the woods. “The pandemic remains a key consideration for us as we
evaluate our performance for the
quarter and plan for the remainder of
the year,” he explained. “At this point,
we feel the market is operating slightly
below 2019 levels with a continued
recovery expected for the remainder
of the year. As we navigate through
the newest phase of the pandemic, we
are mindful that there [continues] to
be some ongoing impact in certain
regions and some stresses to the supply chain.”7
39th International Dental Show 2021
9
[10] =>
industry
SHOW
PREVIEW
Newest digital tools from Amann Girrbach
are patient oriented and enhance teamwork
Connection Kit server is the entrylevel option, and it consists of the
Ceramill Map DRS intra-oral scanner and appropriate scanning software, as well as the connection to
AG.Live. Any order data, including
all the required information, can
therefore be shared seamlessly and
in real time, as the practice and the
laboratory are digitally linked via
AG.Live. This permits same-day dentistry for simple restorations, including those using zirconia, owing to its
use of the Ceramill DRS High-Speed
Zirconia Kit. This is further supplemented by the Ceramill DRS Production Kit, which allows fabrication to be performed directly in the
practice by the dentist. Here, the
laboratory can assist the practice in
terms of design, expertise, service
and advice.
In total, this results in access to
three Ceramill team workflows, depending on the kit equipment and
the team constellation. Owing to the
modular design of Amann Girrbach’s
solutions, it is possible to begin
working with the Ceramill DRS Connection Kit and to upgrade at a later
time to the Ceramill DRS Production
Kit. In addition, the Ceramill DRS
system is fully integrated and all
components are compatible with one
another and originate from a single
source. Thus, Amann Girrbach is
able to take full responsibility for
service, support and the final restoration. Availability of the individual
kits can be requested from respective dental dealerships.
With an expanding portfolio of
digitised solutions such as AG.Live
and DRS, Amann Girrbach supports
dental practices and laboratories on
their journey to a patient-oriented
digital future. In addition to a number of innovations to its proven
CAD/CAM products and materials,
the company will focus on solutions
for interdisciplinary cooperation between dental laboratories and dental practices at its IDS booth (#A010/
B011 in Hall 3.2).
The Ceramill Direct Restoration System (DRS) joins dental technicians and practitioners together in an interdisciplinary and future-oriented team
and enables easy entry into same-day denture fabrication (Same Day Dentistry).
Digitisation in the dental industry is unstoppable—it heralds change
and, at the same time, offers unlimited potential. Digital technology
brings about enormous advantages,
such as the simplification of process steps, reproducibility and a
high degree of predictability.
Making these advantages tangible for dental professionals is precisely the mission that Amann
Girrbach has set itself. Now, after
five years of development, the company has launched AG.Live, its
largest digitisation offensive to date.
AG.Live is a web-based portal for
collaboration between laboratories
and dentists, and it strives for perfection across the exhaustive digital
services that it offers. For example,
the platform is a central tool for
digital case management, a networking, infrastructure and material management tool, and a support
and knowledge database that will
gradually replace the company’s
previous customer portal, C3.
The AG.Live platform also networks machines and materials in
the laboratory, thereby simplifying
processes and increasing quality
and reproducibility. The greatest advancement that the platform offers,
however, is that it links together the
growing global network of dental
professionals who are operating digitally. This link bridges the interdisciplinary gap between dentists and
dental technicians and facilitates future-oriented cooperation. Harnessing this network of new and optimised partnerships, dental participants can focus on their strengths
and better position themselves on
the market.
The interface of the Ceramill
Direct Restoration System (DRS),
with which Amann Girrbach extends the digital Ceramill CAD/CAM
workflow to the dentist, is also provided by AG.Live. The Ceramill DRS
The digital platform AG.Live paves the way for smooth interdisciplinary collaboration.
IDS 2021: exocad announces its
largest ever presence at trade show
Exocad, an Align Technology
company, has announced its expanded presence at the International Dental Show (IDS) 2021. exocad
will showcase its newest software
releases and innovations for dental
technicians and dentists at Booth
A020 in Hall 3.2, where it will have
360 m² of exhibition space and a
multitude of demo stations.
IDS is one of the most important
dates on exocad’s calendar. The
international trade show is held
biennially in Cologne and offers
additional opportunities for
the company to connect
with new partners and
deepen long-standing
relationships.
“Proximity to dental technicians and
clinicians is key for
us at exocad, and for
that reason we are delighted to finally reconnect in person. It was
10
always clear for
us that we’d par-
39th International Dental Show 2021
ticipate in IDS, but noticing how
keen our users and partners are for
trade shows, we’ve decided to extend our presence at this year’s
event,” said Tillmann Steinbrecher,
exocad CEO. “At IDS 2021, we will
showcase our wide spectrum of
innovative solutions for labs and
practices, inviting them to discover
these at our interactive demo stations.”
Participants can experience
exocad’s variety of software solutions,
including DentalCAD, ChairsideCAD
and exoplan, and meet exocad’s own
experts as well as the renowned
dental trailblazers Waldo Zarco Nosti
and Dr Gulshan Murgai.
Exocad will present a new booth
design at IDS 2021, reflecting the
company’s continued innovation
and growth. For those who will not
be able to attend IDS 2021, the trade
show will offer a virtual experience
that will feature many exocad highlights.
On-site participants can find
exocad at booth A020 in Hall 3.2,
and additional information is available at exocad.com/ids.
[11] =>
industry
SHOW
PREVIEW
Dental electric motor company
Micro-NX to launch handpiece
line-up at IDS 2021
Micro-NX is a South Korean company that specialises in manufacturing dental electric motors, including
motors for implant surgery procedures. Its electric motors are manufactured using a technology patented in
China, Japan and the US. They are exported worldwide and are growing in
popularity. At IDS 2021, Micro-NX
will launch a new line of products,
including contra-angle and straight
handpieces available in gear ratios
1:1, 16:1 and 20:1.
The handpieces were developed
with Micro-NX’s own technology. In
the South Korean market in particular, the company’s electric motor,
known as ELEC, boasts a unique market share.
“Not only is the torque strong but
also the precision is high, so when removing prostheses, chair time is reduced by one-third,” says Dr Jung-soo
Kim, head of a dentist’s office, who
has been using the electric motor for
more than ten years. “It is very use-
ful for trimming margins with high
torque at low speed and for precision
preparations which can increase the
completeness of prostheses.” He also
stressed that “the greatest advantage
of ELEC is that it can be adjusted
while checking the rotational speed
directly, so that one can maintain constant rotational speed and torque of
the handpiece”.
Micro-NX is a B2B dental unit and
implant manufacturer. It expects to
expand its business with the launch
of its new handpiece line. The company is concentrating on liaising with
other manufacturers in order to provide products fitting their requirements.
“The electric motor is an essential
part of the handpiece instrument, and
we can meet our customers’ expectations because, with our company,
there is the advantage of being able to
obtain both from a single source,” said
a Micro-NX spokesperson.
As a member of the Daegu Technopark, Micro-NX will be exhibiting
its product portfolio at IDS 2021
(Hall 3.1, Booth L060/M060). More information about the company can be
found at www.micronx.co.kr.
HASS meets highest demands
for aesthetic restorations
At IDS 2021, all-ceramic dental
materials manufacturer HASS (Human-Aid System Supplier) will be presenting a wide range of glass-ceramic
solutions for aesthetic restorations
that meet the requirements of both
chairside and laboratories.
In focus for IDS will be Amber
Mill, which was named a WOW! Product in October 2020 by the Journal of
Dental Technology, published by the
National Association of Dental Laboratories in the US. Amber Mill is available in four shades: high, medium and
low translucency, as well as medium
opacity. It is a highly aesthetic and innovative nano-lithium disilicate CAD/
CAM block with the following advantages:
1. Amber Mill demonstrates both opalescence and fluorescence of natural
teeth.
2. It is possible to vary translucency
with a single block of Amber Mill by
modifying the heat treatment temperature according to the targeted
translucency. This will enhance the
work process efficiency and inventory management for CAD/CAM
milling blocks.
3. The denser and more cross-linked
crystal structure of Amber Mill results in superior physical properties.
4. Less chipping—the outstanding machinability of Amber Mill is evident
from the edges of the milled restorations.
In addition, the company is showcasing other members of its CAD/CAM
line: the Amber Mill Hhybrid ceramic
block and the Zirtooth multilayered
zirconia disk; the glass-ceramic ingots
Amber Press and Amber Press Master
that are suitable for hydrofluoric
acid veneering material; and Amber
LiSi-POZ, an innovative and differentiated product utilising the technique
of lithium disilicate ingot pressing
on a zirconia framework. Dental professionals can also try out Amber Vest,
an ultra-fine phosphate-bound investment for press ceramics, and COCO
Lux, a lighting device for dental photography with mobile phones.
At IDS, the HASS booth O069
can be found in Hall 11.2. Special gifts
will be available on-site. More information about the company can be
found at www.hassbio.com.
Diagnocat AI—a personal assistant in diagnostics
and treatment for every dental team
Despite the development of technologies for
the prevention and treatment of dental disease,
more than 3.5 billion people suffer from oral
disease. Untreated dental caries in permanent
teeth is the most common, and severe periodontal disease affects almost 10% of the global population.
The solution is to recognise that dentistry
today has become so technologically complex
that the quality of treatment is no longer in the
hands of one single doctor. The dental team consists of the dentists themselves, hygienists,
treatment managers and other specialists under
one roof or in different practices. This treatment
team uses many different tools, in addition to
the medical information system, to interact with
one another: messengers, e-mails, task managers, etc. It is evident that most of these standard
services are not customisable for the needs of
dentistry, that they are inconvenient, that they
do not comply with personal data laws and
that they are ultimately ineffective. As a result,
diagnostics and planning are incomplete, comprehensive treatment appears disjointed, and it
is difficult to determine and take into account
the position of individual doctors.
How can artificial intelligence solve
these problems, to make diagnosis
more accurate and optimise treatment?
The innovative Diagnocat dental software
employs artificial intelligence (AI) to create a
platform for effective collaboration between
dentists, managers and patients.
The Diagnocat service consists of four main
components:
1. AI that analyses all types of dental images,
including intra-oral radiographs, panoramic
radiographs and CBCT scans, and assists
the dentist in diagnosis and treatment planning;
2. a cloud to store and share any dental images, including STL files and dental photographs;
3. a task manager for real-time communication, assignment of tasks and notification of
teammates of status changes online; and
4. a clear report for a patient so that he or she
can easily understand that treatment is necessary.
How can Diagnocat be practically
applied in a clinic?
The possibilities of the service can be illustrated using a clinical example. A 44-yearold female patient complained about her smile
because she was dissatisfied with the appearance of her teeth regarding their colour and
size and had decayed and missing teeth. At
the initial consultation with a general dental
practitioner, images using the digital smile
design protocol and CBCT were taken. Integration with most dental imaging equipment
manufacturers allows dentists to automatically create patient accounts and upload images. The doctor discussed her dental health
with the patient using a photographic protocol
and a Diagnocat radiographic report (CBCT
analysis). The treating physician analysed the
automatically created panoramic reformat,
the slices of each tooth and the findings generated by the AI.
Diagnocat identifies the most common
dental pathologies with an accuracy of over
90%. If necessary, the dental professional comments on the findings and corrects and completes the diagnosis. He or she can then send
the AI report in PDF format to the patient or
provide a hard copy.
The treatment coordinator uses the report
to familiarise himself or herself with the clinical case and adds other necessary specialists
to the personal Diagnocat account. The task
planner allows the user to set a deadline and
track the progress of the treatment.
The HIPAA- and GDPR-compliant messenger allows doctors to discuss the case in real
time and comment on dental images—both
from a desktop computer and from a mobile
phone. The notification system sends e-mails
to users when new images are uploaded to
the patient’s account, when messages are received and for other important events.
In the process of dental rehabilitation, a
prosthodontist, oral surgeon and orthodontist
were involved. Throughout the entire treatment
period of 13 months, these doctors used Diagnocat continuously. No additional software products, except for a management information system, were required.
Diagnocat perfectly complements any management information system and can be integrated into it for information exchange and for
automated filling of a tooth chart. Diagnocat is an
indispensable tool for dentists working remotely
and/or dealing with complex dental rehabilitation. More information can be found at www.diagnocat.com. During IDS, Diagnocat will be exhibiting at booth R047 in Hall 10.2.
39th International Dental Show 2021
11
[12] =>
practice & science
SHOW
PREVIEW
Glass hybrids versus composite
Efficacy and cost-effectiveness in a multicentre clinical study.
n Through the Minamata Convention
on Mercury in 2013, the countries of
the EU committed themselves to completely or largely eliminating mercury-containing industrial products
such as dental amalgam from the supply and disposal cycle by 2030.1 In
2020, the EU came to the conclusion
through an expert opinion that not
only the planned phase-down but
even a complete phase-out of dental
amalgam is possible. Accordingly,
dental amalgam is becoming a material of the past. In Germany and many
other countries, however, this development had already been apparent
for some time without the Minamata
agreement. Modern tooth-coloured
restorative materials such as composites or glass ionomers enable metal-
free restoration of tooth structure defects with better aesthetics and less
substance loss during preparation.2
While composites have advantageous physical properties, such as
high flexural strength, their use is
technically demanding. Although the
dental industry has been able to signifi
cantly reduce the complexity of the
treatment steps required for placing a
composite filling in recent years, even
modern one-step adhesive systems in
combination with bulk fill composites—which often have to be applied in
at least two increments, depending on
the cavity dimensions and material—
still require step-by-step application
and adequate drying. In addition, composites exhibit an increased risk of
secondary caries, especially at the gingivo-cervical margins, compared with
amalgam, and the time-saving materials mentioned may be particularly
problematic in this respect.
Glass ionomers, however, were
long considered to be temporary materials with a limited longevity of use in
the posterior region. This was largely
due to the physical properties of these
materials, which exhibited low flexural strength and limited abrasion resistance. Aiming to eliminate these
disadvantages, advanced high-viscosity glass ionomers covered with a
light-polymerised resin coating have
been introduced.3
In 2015, a newer class of restorative materials was launched, the glass
hybrids. These materials are fluoroaluParameters
A considerable range of materials, including glass hybrids and composites, are available for the restoration of posterior dental cavities resulting
from dental caries. (Image: Stasique/Shutterstock.com)
minosilicate glasses reinforced with a
second, smaller and more reactive silicate particle and acrylic acid molecules with higher molecular weight,
which can increase the matrix
cross-linking and, consequently, the
mechanical properties of the material.4, 5 A nano-filled resin coat is used
to cover the restorations and is supposed to increase the resistance of the
material to mechanical forces5, 6 and allows greater surface stability and aesthetics. Even if the resin coat is subject
to certain wear in the masticatory
load-bearing area, it can still be reapplied, and thus, above all, the problem
of abrasion stability can be largely
eliminated.5
Glass hybrids also have several
advantages over composites:
1. They are self-conditioning and
self-adhesive; thus, the application
of an adhesive system is not necessary.
2. They are applied in one increment,
that is, truly in bulk—regardless of
the cavity dimension—among other
things because reliable polymerisation occurs in all layers and independent of light polymerisation
steps.
3. They are also moderately tolerant of
moisture.
In a recently published study, a
modern glass hybrid material was
tested for the first time against an established composite material for the
restoration of two-surface, occlusal–
proximal restorations in molars, that
is, in the load-bearing area. This was a
randomised controlled clinical trial in
which patients with two molars in
need of restoration were randomly assigned to receive the glass hybrid material in one molar and the composite
material in the other molar; the materials were then compared in the same
patient.7 The special feature of this
study was the large number of patients. Moreover, it took place in four
different countries—Croatia, Serbia,
Italy and Turkey. In all four countries,
patients were treated in university
hospitals. Patients had to be at least
18 years old and demonstrate tooth
sensitivity to the vitality test. A total of
180 patients, each with a pair of molars to be restored (i.e. 360 molars),
were included.
The teeth were first cleaned, local
anaesthesia was applied, the molar to
be restored with composite (Tetric Evo-
Countries
Croatia
Italy
Serbia
Turkey
Age (years)
26.5 (7.4)
44.6 (15.8)
31.7 (11.4)
30.6 (11.2)
Sex (f/m)
44/16
16/16
16/12
40/20
Glass hybrid cost
(US$)
92.7 (7.4)
146.1 (12.9)
44.0 (3.3)
66.2 (11.9)
Composite cost
(US$)
126.42 (16.3)
146.2 (19.3)
61.0 (3.5)
128.6 (3.8)
Survival time glass
hybrid (months)
35.1 (3.4)
35.3 (2.3)
34.1 (6.2)
35.0 (3.0)
Survival time composite (months)
34.3 (5.1)
35.0 (4.0)
34.9 (4.6)
35.8 (1.0)
Table 1: Patient characteristics, costs and mean (standard deviation) survival times.
12
39th International Dental Show 2021
Ceram, Ivoclar Vivadent) was isolated
using a dental dam, and the molar to
be restored with a glass hybrid (EQUIA
Forte, GC) was isolated using cotton
rolls, and then the cavity preparation
was performed. Segment matrices
(Palodent Plus, Dentsply Sirona) were
used to shape the proximal contacts. A
two-step self-etching adhesive system
(AdheSE, Ivoclar Vivadent) was applied in the composite group according to the manufacturer’s instructions.
Cavities in the glass hybrid group
were conditioned with 20% polyacrylic acid (CAVITY CONDITIONER,
GC) prior to placing the restoration.
Both materials were then applied according to the manufacturers’ instructions, and the glass hybrid was subsequently coated with a nano-filled resin
coat (EQUIA Coat, GC).
Patients were followed up for a total of three years; the planned follow-up duration was five years. Each
patient was examined by two blinded,
independent and calibrated investigators using the FDI World Dental Federation criteria.7 Statistical methods
were used to determine the mean time
to complication for both groups. Furthermore, the costs for the initial and
subsequent treatments within the
study period, for example for restorative, endodontic or surgical complications, were determined. For this purpose, fee items from the fee schedules
for dentists of the various countries
were used. It should be mentioned
that these fee schedules are applied
very differently in the four countries
and that the costs in the analysis were
determined from a university setting
perspective instead of that of a private
practice. To allow comparability across
the four countries, costs were harmonised using the 2018 purchasing
power parities8 and expressed in US
dollars per tooth. Cost and efficacy differences, that is, the difference in US
dollars per gain or loss in compli
cation-free time (in months), were
finally calculated, and stratified analyses were performed for each country
in addition to the main analysis.
Of the 180 patients, significantly
more were treated in Croatia and Turkey than in Italy and Serbia. In Italy,
the patients were older than in the
other three countries. A total of 32 patients could not be followed up during
the three-year study, and 21 patients
(27 molars) required follow-up treatment owing to complications. The two
materials showed limited differences
in complication-free time. Broken
down by country, the survival time of
glass hybrids tended to be longer than
that of composites in Croatia and Italy
and tended to be shorter in Serbia and
Turkey. Overall, however, the differences were minimal and not statistically significant.
The results were completely different for the costs (Table 1). In Croatia, Serbia and Turkey, composite was
initially significantly more expensive
than glass hybrid. In these three countries, the use of glass hybrid also saved
money over the entire study period.
When looking at the cost-effectiveness
difference, it became clear that any effectiveness advantage of composite
was minimal, but the cost difference
was relatively large. Overall, each additional month without complications
for the composite compared with the
glass hybrid group cost US$270. However, with slight variations in this
value in the different centres, this exact pattern was also confirmed in the
four different countries.
The results of this study are relevant on many levels. It is a large randomised controlled clinical trial conducted in four different countries.
The high methodological quality and
randomised design confer high internal validity, and thus the study results are presumably robust. Based
on the fact that the study results
were similar across the four centres
in very different patients, the external validity, that is, the generalisability of the study results, can also be
assumed to be high. In addition, a
high methodological standard was
implemented: the investigators were
blinded (as far as this was possible as
glass hybrid restorations and composite will have been identifiable for
the investigator in individual cases)
and calibrated before the examinations, and established examination
criteria were applied. The consideration of multiple end points, such as
complication-free time and cost-effectiveness, should also be emphasised.
This study is one of the first to
compare the two existing amalgam
alternatives, composite and glass hybrid, in such a design and for a crucial indication—restorations in the
load-bearing
posterior
region
(Fig. 1).2 The results are relevant,
among other things, because even in
this difficult indication, glass hybrids
performed overall on a par with composites (with minor differences between countries). It is also relevant
that glass hybrids were significantly
more favourable than composites in
almost all the centres when it came
to costs—both initially and in the long
term. The latter in particular should
be emphasised, as long-term cost-effectiveness can be significantly influ-
[13] =>
practice & science
SHOW
PREVIEW
Editorial note: A complete list of references can be obtained
from the publisher. The study, titled “Cost-effectiveness of
glass hybrid versus composite in a multi-country randomized trial”, was published in the April issue of the Journal
of Dentistry.
1a
1b
1c
1d
1a–d: Restoration with the glass hybrid EQUIA Forte in the multicentre study. (a) Directly after placement. (b) Recall
after one year. (c) Recall after two years. (d) Recall after three years.
enced by complications over the follow-up period. Numerous studies in dentistry have
shown that initially less expensive interventions are not necessarily cost-effective in the
long term; a high degree of complications
may well offset initial savings and make an
initially less expensive alternative more expensive in the long term.9, 10 This was not the
case in this study; glass hybrids were initially
less expensive in three centres, and they
were able to maintain this cost advantage in
the long term, partially because the complication rates of glass hybrids and composites
were similar. It must be added that, based on
this one study, it is not yet possible to make
a complete generalisation of the results; the
data on glass hybrids for use in larger
load-bearing posterior cavities are so far of
limited quantity. Although in vitro studies
and the present randomised controlled trial
are promising, further robust clinical data,
ideally from practice-based multicentre studies, should be collected before a final comparison between glass hybrids and composites
can be made for this indication. Nevertheless, it should be emphasised once more that
glass hybrids show an amalgam-like application. Moreover, the study confirmed a clinical
performance similar to that of composites
and a high cost-effectiveness. 7
References
[1] United Nations Environmental Programme, Minamata
Convention on Mercury, United Nations, New York,
2013.
[2] F . Schwendicke, G. Gostemeyer, M. Stolpe, J. Krois,
Amalgam Alternatives: Cost-Effectiveness and Value
of Information Analysis, Journal of Dental Research
(2018) 22034518782671.
[3] A.M. Kielbassa, E.P. Oehme, N. Shakavets, M. Wolgin,
In vitro wear of a (resin-coated) high-viscosity glass
ionomer cement and a glass hybrid restorative system,
Journal of Dentistry (2020) 103554.
[4] M Moshaverinia, A Navas, N Jahedmanesh , KC Shah ,
A Moshaverinia , S Ansari. Comparative evaluation of
the physical properties of a reinforced glass ionomer
dental restorative material. J Prosthet Dent. 2019
Aug;122(2):154–9. doi: 10.1016/j.prosdent.2019.03.012.
Epub 2019 Jul 17.
[5] F Schwendicke, J Kniess S, Paris, U Blunck. Margin
integrity and secondary caries of lined or non-lined
composite and glass hybrid restorations after selective excavation in vitro. Oper Dent 2017 42:155–64.
https://doi.org/10.2341/16-095-L.
[6] Z .B. Kutuk, O. Ozturk, F.Y. Cakir, S. Gurgan. Mechanical performance of a newly developed glass hybrid
restorative in the restoration of large MO Class 2 cavities. Nigerian Journal of Clinical Practice, Vol. 22,
Issue 6, June 2019. http://www.njcponline.com. IP:
188.118.59.242.
[7] I. Miletia, A. Baraba, M. Basso, M.G. Pulcini, D. Markovi, T. Peri, C.A. Ozkaya, L.S. Turkun, Clinical Performance of a Glass-Hybrid System Compared with
a Resin Composite in the Posterior Region: Results of
a 2-year Multicenter Study, The Journal of Adhesive
Dentistry 22(3) (2020) 235-247.
[8] O
ECD, Purchasing power parities (PPP) (indicator),
2020. (Accessed 20 November 2020).
[9] F . Schwendicke, Less Is More? The Long-Term Health
and Cost Consequences Resulting from Minimal Invasive Caries Management, Dental Clinics 63(4) (2019)
737–49.
[10] F . Schwendicke, J. Krois, M. Robertson, C. Splieth, R.
Santamaria, N. Innes, Cost-effectiveness of the Hall
Technique in a Randomized Trial, Journal of Dental
Research (2018) 22034518799742.
About the author
Prof. Falk Schwendicke
Charité—Universitätsmedizin Berlin
Aßmannshauser Str. 4–6
14197 Berlin, Germany
falk.schwendicke@charite.de
Prof. Falk Schwendicke is the head of the Department
of Oral Diagnostics, Digital Health and Health Services
Research at Charité—Universitätsmedizin Berlin in
Germany. He has a demonstrable track record of clinical and scientific excellence in the fields of diagnostics
and operative, preventive and data-driven dentistry.
Prof. Schwendicke’s research is aimed at answering
questions of high clinical relevance. His research focus
is on cariology and restorative dentistry, preventive and
public health dentistry, dental diagnostics and artificial
intelligence, as well as health economics and health
services research. He has authored over 300 articles,
edited various books and provided over 20 book chapters on a range of issues—from caries management
to health economics.
Prof. Schwendicke has been awarded a range of
prestigious awards, among them the International Association for Dental Research’s Basil G. Bibby Young
Investigator Award and Lion Dental Research Award,
numerous awards from the Deutsche Gesellschaft für
Zahnerhaltung (German society of conservative dentistry) and the David Sackett Award from the German
Network for Evidence-based Medicine.
He reviews for over 40 peer-reviewed journals, among
them The Lancet, as well as for various national funding agencies. He has served on the editorial boards
of various dental journals and is presently an associate
editor of the Journal of Dental Research.
AD
REGISTER FOR FREE
DT Study Club – e-learning platform
Dentistry's largest online education community
webinars / live operations / online CE events / CE credits
www.dtstudyclub.com
@DTStudyClub
39th International Dental Show 2021
Tribune Group is an ADA CERP Recognized Provider.
ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by
boards of dentistry.This continuing education activity has been planned and implemented in accordance with the standards of the ADA Continuing Education Recognition Program (ADA CERP) through joint efforts between Tribune Group and Dental Tribune Int. GmbH.
13
[14] =>
© Guenter Albers/Shutterstock.com
travel
SHOW
PREVIEW
When in Cologne, get out and about
Cologne Crane Houses near the Rhine.
The museum Ludwig for modern art in front of the Cologne Cathedral.
© travelview/Shutterstock.com
will not regret juggling your time at
IDS to allow for an excursion into
the heart of the city. A taste of what
Cologne has to offer may leave you
with a thirst for more.
Cologne by day
Most visitors will head to the cathedral. It is Germany’s most visited
landmark, after all, and an important
site of pilgrimage in Europe. Keep an
eye out for the Shrine of the Three
Kings and the bold stained-glass windows in the south transept—they consist of 11,500 identically sized pieces
of coloured glass and were installed
in 2007 by Gerhard Richter, arguably
Germany’s most celebrated living
14
thing for everyone. A Segway tour
will take you through, and beyond,
the inner city, whereas a guided
brewery tour will help you to discover the hidden, hoppy lanes of the
historic city centre. You can explore
the social fabric of Cologne by taking a “Love stories of Cologne” tour,
or an LGBQT tour. What role has
mustard played in the history of Cologne? What is carnival really all
about? And are people in Cologne actually obsessed with chocolate? Visiting one of the city’s many specialty
museums may answer these questions, while posing many others—
visit tripadvisor.com for more information on these activities.
39th International Dental Show 2021
Visitors to IDS should consider
taking a break every once in a while,
and what better way to do so than by
enjoying a piece of cake and a cup of
hot coffee? The multicultural Ehrenfeld district (north-west of the inner
city) offers a relaxed and interesting
atmosphere, and a number of good
cafes. Visit the cosy and slightly hidden Kaffeebud Ehrenfeld to find out
what a “third wave” coffee is, or sample a creamy latte and authentic
New York-style cheesecake at Cafecafe Ehrenfeld (cafecafe.de), where
the breakfast menu is also to be recommended.
If you are longing for a holiday
feel and find yourself in the southern
part of the inner city, Sabor ’ermoso
has surfboards hanging on the walls,
little Spanish delicacies and an excellent cappuccino—perfect to unwind
after a busy day of dental business.
Cologne by night
As the sun goes down, Cologne
reawakens in a different light, and so
it is easy to enjoy the city once the
trade fair halls close. Keep an eye out
for the Büdchen (kiosks), which are
found on many street corners. Locals
will stop by one of them for drink
before heading to their favourite
Kölsch-serving bar, so why not join
them? The trendy bar Zum scheuen
Reh is located next to the Köln West
train station and is perfect for starting the evening: get to know some
Cologne locals while enjoying a
couple of long drinks—non-alcoholic
drinks are also plentiful—and the live
music on offer in the bar’s outdoor
area (www.zum-scheuen-reh.de).
Afterwards, you can hit Bumann
& SOHN, which is close to the Ehrenfeld train station. It is here that beer
garden atmosphere meets urban industrial vibes, and this is where the
dynamic, alternative flair of this district can be felt best (www.bumannundsohn.de). Coming early pays
off!
The next destination is STAPEL.
BAR, which is located within walking
distance from Bumann & SOHN at the
heart of the Helios district. At STAPEL.
BAR, you can buy freshly brewed
Gaffel Kölsch from the barrel and
experience a colourful music programme, including DJs, live acts and
local artists (www.stapel.bar). Are
you intrigued by the original steel
dartboard? Then this is also the place
for a casual round of darts. If you are
in the mood for dancing, you can
spend the rest of the night in the
northern part of Cologne, between
Ehrenfeld and Nippes at the Odonien
nightclub, to be exact. Apart from
concerts, plays, flea markets and
open-air film showings, you can
dance to predominantly electronic
club music in the midst of obscure
metal sculptures and impressive fireworks.
Arts and culture
Cologne has a great deal to offer
as far as arts and culture are concerned. Collections of famous canonical artworks can be found in the celebrated Museum Ludwig—this might
be your thing. However, the museum’s
current temporary exhibition, “In
Situ: Photo Stories on Migration”, offers a window into local history.
The personal photographs on show
document the period between 1955
and 1989 (when the social make-up of
Cologne was forever altered by an
influx of migrant workers) and may
change the way that you see and
understand the city today (museumludwig.de).
Speaking of understanding Cologne, how has this carnival-obsessed
city negotiated social distancing and
the cancellation and scaling down of
two successive carnival seasons? The
exhibition “Alaaf auf Abstand. Bilder
einer anderen Session” is taking
place online and in public spaces
across the city, and is therefore also
a must for virtual visitors to IDS. Organised by Kölnisches Stadtmuseum,
it features photographs and digital
media that investigate the hidden
dynamics of a pandemic carnival
season. A virtual tour of the show, followed by a real-life scavenger hunt
through the inner city, is highly recommended (alaaf-auf-abstand.de).
Cologne is also home to the Käthe
Kollwitz Museum Köln, which specialises in exhibiting work by and relating to the pioneering female artist
(1867–1945), who is nowadays associated with the expressionist movement. A new exhibition—“Der Ausdruck der Augen vergrübelt und
fern”—presents a variety of Kollwitz’s
portraits of friends, family members
and political figures across a range of
media (kollwitz.de).
There are many, many more museums of note—the Museum für Angewandte Kunst Köln, the WallrafRichartz Museum, the Museum für
Ostasiatische Kunst Köln, just to
name a few. Film buffs should pay a
visit to the Filmforum NRW, and one
of many other highlights of the city
for cineastes is the ODEON, a cosy,
retro-style movie theatre that shows
art-house productions.
Food and drinks
Whether you are interested in
music, art or history, Cologne and its
attractions are best explored on a full
stomach. For quite some time now, an
unofficial institution of the city has
been the falafel. Usually, it is freshly
made with coriander or parsley (either Lebanese or Syrian style) and
fried to perfection. In Cologne, these
spicy chickpea balls taste like nowhere else in Germany and are preferably eaten with a giant spoonful of
tahini. Try it yourself: take a stroll
down Venloer Street in Ehrenfeld and
see how long you can resist the smell
of the various oriental bistros and cafes. Arguably, the best falafel can be
found at the traditional Habibi (habibikoeln.de), in doughnut shape at Vegan Food Revolution (vegan-food-revolution.de) or at Beirut restaurant,
while enjoying a beautiful view over
the Rhine (beirut-restaurant.de).
If your tastes are more carnivorous, however, then you should pay
Karl Hermann’s a visit. Also located
on Venloer Street, here you will find
high-quality burgers with freshly
minced and succulently grilled meat
patties—free from antibiotics—in a
fluffy brioche bun (karlhermanns.
de). If you still have some room left
afterwards, you can hit Frittenwerk
Köln for some delicious homemade
fries (frittenwerk.com/koeln). Enjoy
fries made from regular or sweet
potatoes with chive-and-cheese topping. Whatever you choose, make
sure to also try the lemon aioli and
the homemade guacamole. Naturally, humans are not like goats, and
these large amounts of salt need to
be counteracted somehow, which is
why a visit to one of the Kölsch-serving traditional restaurants is a necessity. Enjoy a chilled Kölsch beer
like a true local at Bierhaus en d’r
Salzgass (bierhaus-salzgass.de) or
Weinhaus Vogel (weinhaus-vogel.
de), where not only simple, authentic Cologne food is served, but also
the spirit of the city can be experienced. Enjoy!
© Larisa Blinova/Shutterstock.com
painter. You may prefer to simply
take a selfie in front of the cathedral’s superlative facade and then
head off. Rest assured—Cologne has
much more to offer!
Just south of the cathedral is the
Heinzelmännchen fountain (a nod to
the city’s love of folklore) and the
900-year-old city hall. A short ride
west will bring you to the expansive,
park-like Melaten cemetery, home to
the remains of many notable residents—including Johann Maria Farina, who invented eau de cologne,
and Alfred Nourney, Cologne’s own
Titanic survivor.
To get to know the city from a
different perspective, take a city
tour, the themes of which are so diverse that there is literally some© ChrisAndF/Shutterstock.com
Cologne is one of Germany’s most
diverse, historic and rowdy cities—famous in equal measure for its architecture, night life, art and gastronomy. Read on for selected tips on
finding your feet, finding something
to eat, and finding some of the many
surprises that the city has to offer.
Cologne is an old city, having
been founded by the Romans nearly
2,000 years ago. Since then, it has
given us many different things, including the world’s tallest cathedral,
a type of perfume marketed for men,
and a long list of influential and notable residents. Nowadays, the largest
city on the Rhine has come into its
own as a stronghold of the German
carnival tradition and a bastion of
contemporary European culture. You
Chickpea-falafel-balls with white sauce and pita-bread.
[15] =>
service
SHOW
© Koelnmesse
PREVIEW
Useful information
Organisers
Koelnmesse and the Society for
the Advancement of the Dental
Industry (GFDI), the commercial
enterprise of the Association of the
German Dental Industry (VDDI)
ucts and system solutions and will
enable the streaming of webinars,
press conferences, events and one-toone conversations between company
representatives and current/prospective clients.
Venue
Hygiene protocols
Koelnmesse, Messeplatz 1,
50679 Cologne, Germany, for
in-person attendance
The IDSconnect digital platform
for virtual participation
Face masks must be worn to
enter the trade fair ground. Face
masks will be provided at entrance
areas for visitors and exhibitors who
do not have their own. Additional
masks and disinfectant products are
available for purchase in Koelnmesse
shops at the venue.
Full or partial face shields are
not a substitute for mouth and nose
protection, as the shields only stop
aerosols to a limited extent. Therefore, transparent visors are permissible only in verified individual cases.
In accordance with the Coronavirus Protection Ordinance, people
with COVID-19 symptoms—coughing,
sniffles, loss of smell or taste, fever,
etc.—are not allowed to enter the exhibition grounds.
Koelnmesse’s #B-SAFE4business
concept includes a comprehensive catalogue of protective hygiene measures. Personalised tickets and contactless identity checks and bag searches
at the entrances will be available,
while trained personnel will be present to ensure that all hygiene regulations can be easily observed and followed at each exhibitor’s booth.
Visitors to IDS 2021 will be required to install the eGuard mobile
application. This app is designed to
guide visitors so that they can best
avoid crowds and maintain appropriate social distancing.
Exhibition opening hours
22–25 September 2021
Daily from 9:00–18:00 for visitors
Daily from 8:00–19:00 for exhibitors
Admission price
Day ticket: €13.00
Day ticket for students: €7.50
IDSconnect: Free with registration
Ticket distribution
In line with the Coronavirus
Protection Ordinance of the German
state of North Rhine-Westphalia, central registration is obligatory before
entering the venue to ensure the
collection of the contact data. For
this reason, no admission tickets for
IDS 2021 will be offered on-site, and
ticketing will be paperless.
Tickets must be purchased online and will be available from the
digital IDS ticket shop from the end
of July 2021. To obtain an admission
ticket, all visitors, exhibitors or journalists must upload a recognised digital proof of complete vaccination,
testing or recovery.
In-person visitors are eligible for
limited free public transport to and
from the exhibition venue. See the
event website for more information.
IDSconnect
In tandem with the physical exhibition, the IDSconnect digital platform will offer information on prod-
Approved vaccines
The following vaccines are currently approved in Germany and
the European Union: BioNTech/Pfizer,
Moderna, AstraZeneca and Johnson &
Johnson.
Any individuals who have been
vaccinated with another vaccine
that has not been approved in the
EU are additionally required to present a valid PCR test or another test
taken within 48 hours prior to their
journey’s commencement.
Visa requirements
Schengen regulations mean EU
nationals do not require a visa to
enter the Federal Republic of Germany. Additionally, passport holders of 62 other nations may enter the
country without a visa for business
and travel purposes and remain for
up to 90 days. All other foreign
nationals must hold a valid visa to
visit the country. Visit the website
of the Federal Foreign Office for the
most current information.
Since the German Federal Government classifies trade fair exhibitors and visitors as “business travellers with an important reason”,
there are no longer any formal, fundamental obstacles to participating
in a trade fair in Germany.
Getting to Cologne
Travellers from around Europe
and further afield can get to Cologne
by air, rail or car. Cologne Bonn Airport is served by most European and
international airlines and is located
just outside of the city. Düsseldorf
Airport is 65 km from Koelnmesse
and the European aviation hub of
Frankfurt Airport is located around
180 km from the showground.
Travellers arriving by air can
take advantage of special prices being offered by the Lufthansa Group,
the IDS’s official airline, and those
travelling by rail can make use of
discounted fares offered by the German train service Deutsche Bahn.
See the IDS site for comprehensive
travel information.
Getting to and from the
show
IDS 2021 ticket holders can use
public transport within both the
Rhein-Sieg and the Rhein-Ruhr
transport areas free of charge. The
Koelnmesse grounds are well con-
nected to the city’s transport network. Suburban (S-Bahn) Lines 6, 11,
12 and 13 depart from the Köln
Messe/Deutz train station (opposite
the south entrance) and reach Cologne main station (Köln Hauptbahnhof) in just a few minutes. Underground Lines 1 and 9 stop at the
Bahnhof Deutz station (3 minutes’
walk from the south entrance), and
3 and 4 stop at the Koelnmesse station (east entrance). Taxi ranks can
be found at all four main entrances,
while the Hohenzollern Bridge offers
an open-air alternative if the weather
is fine.
Internet
Wi-Fi is available free of charge
via the WLAN network #hotspot.
koelnmesse after registering on the
portal site.
Money
Germany uses the euro as legal
tender and the exchange rates as at
26 July were €0.85 to US$1, €1.17
to £1 and €0.0077 to ¥1.
Contactless payment will be
accepted throughout the venue.
COVID-19-related
cancellation
If IDS 2021 is postponed or cancelled by Koelnmesse, prospective
attendees will be reimbursed for all
tickets already paid for. Voucher codes
will no longer be valid; new codes
will be made available for the new date.
Important numbers
Police, fire and ambulance: 112
Medical centre, Hall 7:
+49 221 821-3517
medical centre, Hall 11.1:
+49 221 821-2608
Koelnmesse visitor hotline:
+49 180 677-3577
Security Office North:
+49 221 821-2551 or -2552
Security Office East:
+49 221 821-2549 or -2550
About the publisher
Editorial/Administrative Office
ARGE IDS today GBR
Dental Tribune International GmbH
OEMUS MEDIA AG
Holbeinstraße 29
04229 Leipzig
Germany
Chief Content Offices
Claudia Duschek (V.i.S.d.P.)
Phone
+49 341 48474-302
Production Executive
Gernot Meyer
Fax
+49 341 48474-173
Production
Matthias Abicht, Kim Beyer, Max Böhme, Alexander Jahn,
Frank Jahr, Pia Krah, Stephan Krause, Josephine Ritter,
Franziska Schmid, Nora Sommer, Laura Wajsprych
German e-paper issue
www.zwp-online.info
Editors
Brendan Day, Franziska Beier, Jeremy Booth,
Johannes Liebsch, Monique Mehler, Iveta Ramonaite,
Nathalie Schüller, Magda Wojtkiewicz
International e-paper issue
www.dental-tribune.com
Publisher
Torsten Oemus
Representative, Dental Tribune International GmbH
Torsten Oemus
Representatives, OEMUS MEDIA AG
Ingolf Döbbecke, Lutz Hiller, Jürgen Isbaner
today will appear in advance of the 39 th International
Dental Show in Cologne, 22–25 September 2021.
The newspaper and all articles and illustrations therein
are protected by copyright. Any utilisation without prior
consent from the editor or publisher is inadmissible
and liable to prosecution. No responsibility shall be assumed for information published about associations,
companies and commercial markets. General terms
and conditions apply; legal venue is Leipzig, Germany.
39th International Dental Show 2021
15
[16] =>
Personal assistant
of every dental
team in diagnostics
and treatment
planning
Messenger
GP report
Task manager
Visit us at IDS
USA Pavilion, hall 10.2, booth R 047
With the support
of AI you will never
miss out even on
the smallest details
during the complex
treatment
)
[page_count] => 16
[pdf_ping_data] => Array
(
[page_count] => 16
[format] => PDF
[width] => 794
[height] => 1134
[colorspace] => COLORSPACE_UNDEFINED
)
[linked_companies] => Array
(
[ids] => Array
(
)
)
[cover_url] =>
[cover_three] =>
[cover] =>
[toc] => Array
(
[0] => Array
(
[title] => The show must go on—dental industry looks ahead confidently
[page] => 1
)
[1] => Array
(
[title] => “IDS will light the way for the whole dental industry” – An interview with Mark Stephen Pace
[page] => 2
)
[2] => Array
(
[title] => News
[page] => 4
)
[3] => Array
(
[title] => For patients looking for high-quality dentistry, IDS provides the answers
[page] => 6
)
[4] => Array
(
[title] => News
[page] => 7
)
[5] => Array
(
[title] => Top three trends influencing US dental bone grafting industry in 2021
[page] => 8
)
[6] => Array
(
[title] => The pandemic continues to bite: COVID-19 and the dental market
[page] => 9
)
[7] => Array
(
[title] => Products in focus
[page] => 10
)
[8] => Array
(
[title] => Practice & science
[page] => 12
)
[9] => Array
(
[title] => Travel tips, useful information & imprint
[page] => 14
)
)
[toc_html] =>
[toc_titles] => The show must go on—dental industry looks ahead confidently
/ “IDS will light the way for the whole dental industry” – An interview with Mark Stephen Pace
/ News
/ For patients looking for high-quality dentistry, IDS provides the answers
/ News
/ Top three trends influencing US dental bone grafting industry in 2021
/ The pandemic continues to bite: COVID-19 and the dental market
/ Products in focus
/ Practice & science
/ Travel tips, useful information & imprint
[cached] => true
)